Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,alpha-actinin binding (GO:0051393),0.914231605543773,2.1587217745435243,0.0,0.0,0.0,14/24,4.42%,PDLIM3;SYNPO2;PALLD;MYOT;LDB3;TTN;CACNA1C;PDLIM1;NRAP;PDLIM5;MYPN;KCNA5;KCNN2;PDLIM7
prerank,actin binding (GO:0003779),0.7231274641112466,2.1296042822561927,0.0,0.0,0.0,42/170,6.28%,PDLIM3;SYNPO2;TPM2;CAP2;DMD;KCNMA1;TPM1;LDB3;MYOZ2;TNNI2;SMTN;TNNC2;ABRA;PDLIM1;NRAP;PDLIM5;CALD1;LMOD2;ACTN4;TNNT3;MYL2;VCL;MICAL2;SYNPO2L;LMOD3;SYNE1;FERMT2;MYH9;MYL3;MYO9B;LCP1;MRTFA;ITGB1;MAP1B;FHL3;SLC6A2;PDLIM7;UTRN;SYNE2;GC;MAPT;SORBS1
prerank,muscle alpha-actinin binding (GO:0051371),0.948083231077574,2.0981984867798684,0.0,0.0003268410489370842,0.001,9/15,0.96%,PDLIM3;SYNPO2;PALLD;LDB3;TTN;PDLIM1;NRAP;PDLIM5;MYPN
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.8013373134055664,-2.0860024535332786,0.0,0.002079643288303769,0.002,4/13,2.30%,BMP6;BMP7;BMP4;CDH5
prerank,BMP receptor binding (GO:0070700),-0.8013387398332441,-2.047636822289527,0.0,0.002599554110379711,0.005,4/12,2.30%,BMP6;BMP7;BMP4;CDH5
prerank,retinoid binding (GO:0005501),-0.6475960157813642,-1.9317324587381117,0.0028328611898017,0.02114304009775498,0.056,6/22,4.19%,ALDH1A2;RBP1;PTGDS;CYP26B1;ABCA4;RBP4
prerank,actinin binding (GO:0042805),0.8580535183863829,1.9238821268818451,0.0,0.07966750567841427,0.222,9/21,4.09%,SYNPO2;MYOT;TTN;CACNA1C;PDLIM5;CSRP1;CSRP3;KCNA5;KCNN2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.8732767853294248,1.8817892643844303,0.0,0.1421758562876316,0.413,2/15,0.33%,JPH2;OBSCN
prerank,myosin binding (GO:0017022),0.7194092681942428,1.8814079579340028,0.0012836970474967907,0.11913356233756718,0.414,6/55,1.34%,MYBPC1;MYLK2;DMD;CALD1;ACTA1;MYL2
prerank,titin binding (GO:0031432),0.8800225023386363,1.8675320562642073,0.0,0.12816838276175657,0.497,5/13,3.15%,MYBPC1;OBSCN;TCAP;TRIM63;CAMK2D
prerank,tropomyosin binding (GO:0005523),0.8492388308659652,1.849274944116905,0.004739336492890996,0.14523999112141678,0.578,5/16,1.60%,LMOD1;CALD1;LMOD2;TNNT3;LMOD3
prerank,voltage-gated calcium channel activity (GO:0005245),0.7215526043201416,1.8433455572305186,0.0013908205841446453,0.14065059805925856,0.606,7/37,4.25%,CACNB2;RYR1;CACNA1S;CACNA1C;CACNA2D1;CACNA1H;CACNB4
prerank,high voltage-gated calcium channel activity (GO:0008331),0.8997092969828153,1.813313998868213,0.0018214936247723133,0.19080980436946973,0.751,4/10,4.25%,CACNB2;CACNA1S;CACNA1C;CACNB4
prerank,adenylate cyclase binding (GO:0008179),0.8797783367252571,1.806961413598344,0.007434944237918215,0.18817130571986856,0.78,6/10,7.26%,CAP2;AKAP6;ADCY5;ADCY2;CALM1;CAP1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.7072525427195585,1.8028848927469383,0.0013736263736263737,0.18278585661806432,0.796,11/42,7.35%,NEXN;PALLD;PDLIM1;PDLIM5;MYPN;ROBO3;ANXA1;JAM3;DSCAM;CD200;CNN3
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5749075516079736,-1.7910847468121263,0.003067484662576687,0.13959605572739048,0.382,9/26,8.03%,SLC6A13;SLC16A12;ABCG2;SLC16A9;SLC6A1;SLC6A12;SLC6A6;SLC16A1;SLC16A11
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.8768310903352905,1.788529479005526,0.0034602076124567475,0.20198776824311804,0.858,3/11,1.66%,RYR1;RYR2;ITPR1
prerank,cell adhesion mediator activity (GO:0098631),0.7678185203113764,1.7758790015126316,0.006379585326953748,0.21508475598981117,0.889,7/24,6.20%,NEXN;PALLD;MYPN;BCAM;ROBO3;JAM3;DSCAM
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.7560657508958609,1.7692738956579541,0.00625,0.21774150680188548,0.908,2/24,0.33%,JPH2;OBSCN
prerank,calcium activated cation channel activity (GO:0005227),0.7872537476253665,1.7635116463352012,0.016556291390728478,0.21761485589542237,0.913,7/17,8.74%,KCNMA1;ANO1;KCNMB1;ANO6;KCNN2;ANO10;TRPM4
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.6652979207201843,1.75145414150766,0.009055627425614488,0.23238398579426683,0.931,17/55,12.48%,CACNB2;RYR1;ATP2A1;RYR2;ATP2B4;ATP2A2;ITPR1;SLC8A2;PKD1L3;TRPV2;ATP2B1;TRPC5;ATP2A3;ANXA9;PANX1;CHRNA7;TRPM2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.7100580902510684,1.7400704753169574,0.009668508287292817,0.24725525352090416,0.952,4/34,3.92%,JPH2;OBSCN;FERMT2;MYO1B
prerank,voltage-gated cation channel activity (GO:0022843),0.6081625822159756,1.737561915961029,0.0011547344110854503,0.23919604134053452,0.957,13/97,5.58%,CACNB2;KCNMA1;RYR1;CACNA1S;CACNA1C;CACNA2D1;GRIN2C;KCNQ5;KCNA5;KCNQ4;CACNB4;KCNB1;KCNH1
prerank,ligand-gated calcium channel activity (GO:0099604),0.7773503914265544,1.7371433365743523,0.00778816199376947,0.2279716316336162,0.958,4/19,2.87%,RYR1;RYR2;ITPR1;GRIN2C
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.8217244317258127,1.7295821769820772,0.01967799642218247,0.23541893839153977,0.966,6/12,11.98%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,P-type ion transporter activity (GO:0015662),0.8206669493498235,1.7175463802352555,0.019097222222222224,0.2541783411938442,0.972,5/12,10.32%,ATP2A1;ATP2B4;ATP2A2;ATP2B1;ATP2A3
prerank,calcium-activated potassium channel activity (GO:0015269),0.8310739272579335,1.7152705094293454,0.016574585635359115,0.24802972470208118,0.973,3/11,4.09%,KCNMA1;KCNMB1;KCNN2
prerank,NADPH binding (GO:0070402),0.808021856860049,1.7127143437525598,0.019332161687170474,0.24390513276929907,0.976,2/13,3.45%,KCNAB1;CRYZ
prerank,miRNA binding (GO:0035198),-0.5324383403352236,-1.7047606055904172,0.006289308176100629,0.311738528916735,0.727,17/30,34.50%,AGO3;PUM1;MATR3;ZC3H7A;TUT4;PNPT1;ZC3H12A;FMR1;TUT7;ZC3H7B;YBX1;RBM10;AGO4;ZC3H10;HNRNPA2B1;ELAVL1;SPOUT1
prerank,anion transmembrane transporter activity (GO:0008509),-0.6765586009501541,-1.6982458243477383,0.009216589861751152,0.27901880784742233,0.751,5/12,8.18%,ABCG2;SLCO2B1;SLC39A8;SLC22A6;SLC4A2
prerank,GABA-A receptor activity (GO:0004890),0.7559642594187383,1.6882519473342734,0.026101141924959218,0.2895288747904266,0.991,6/18,11.98%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.6752590279792025,1.6881840024494892,0.02112676056338028,0.27850628612311923,0.991,3/38,1.87%,JPH2;OBSCN;HIP1
prerank,mannosyltransferase activity (GO:0000030),-0.5932886572980414,-1.6840747848835973,0.005698005698005698,0.27896929253103414,0.805,9/21,21.60%,TMTC1;TMTC2;DPY19L4;TMTC4;DPY19L1;PIGV;ALG1;ALG12;POMT1
prerank,diacylglycerol kinase activity (GO:0004143),0.8082331316467504,1.6774046717550912,0.023679417122040074,0.2930674738802521,0.995,2/11,0.44%,DGKB;DGKG
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.8281791126103627,1.6613233349156207,0.02824858757062147,0.32311739555812236,0.998,4/10,9.21%,GABRE;GABRA4;GABRA5;GABRG1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.7204339915855816,1.6580440557346956,0.02,0.3201239018623772,0.999,4/23,6.54%,JPH2;HIP1;CLVS1;PHLDA3
prerank,vinculin binding (GO:0017166),0.7939591027655593,1.6537156306069576,0.025179856115107913,0.3212847511051537,0.999,5/11,7.36%,DMD;ACTN1;UTRN;TLN1;RTCB
prerank,cation channel activity (GO:0005261),0.5755972320942374,1.6450073776468828,0.007017543859649123,0.3333778699158259,0.999,23/94,12.48%,CACNB2;RYR1;RYR2;TMEM38B;ASIC3;TRPC6;ANO1;ANO6;KCNQ4;PKD1L3;TRPV2;CALHM5;ANO10;TRPM4;TRPC5;ABCC8;TMEM38A;ANXA9;PANX1;KCNK3;KCNA2;CHRNA7;TRPM2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7974444584689189,1.64413440648919,0.04,0.32550304339299796,0.999,1/10,0.36%,NCF2
prerank,potassium channel regulator activity (GO:0015459),0.6349973483239145,1.6438166159805778,0.03137254901960784,0.31641184819372814,0.999,8/49,8.12%,KCNAB1;FLNA;KCNMB1;SLC5A3;KCNE4;KCNIP3;ENSA;WNK2
prerank,filamin binding (GO:0031005),0.7772080611292747,1.6392819506490766,0.042704626334519574,0.31921796211922804,0.999,2/11,2.54%,SYNPO2;DPYSL4
prerank,phosphatidic acid binding (GO:0070300),0.7472895762095919,1.6324150804253916,0.02912621359223301,0.32715855167033736,0.999,5/19,7.68%,JPH2;PACSIN2;MARK1;RAPGEF6;OPA1
prerank,calcium channel activity (GO:0005262),0.5792065807434679,1.6242959287110144,0.014218009478672985,0.33825324889580405,0.999,18/84,12.48%,CACNB2;RYR1;RYR2;CACNA1S;CACNA1C;TRPC6;CACNA2D1;CACNB4;PKD1L3;TRPV2;NCS1;TRPM4;TRPC5;ANXA9;PANX1;CACNA1B;CHRNA7;TRPM2
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.6256076604967552,-1.6164167804372545,0.012531328320802004,0.48455688617477816,0.946,5/15,7.39%,PIK3CA;PI4KA;PIK3R3;PI4K2A;PIK3CB
prerank,calcium ion binding (GO:0005509),0.5305074351648502,1.6099214614022657,0.0010090817356205853,0.36743117379832474,0.999,40/323,5.70%,ASPN;SLIT3;SLIT1;RYR1;ATP2A1;TTN;CDH6;RYR2;AOC3;TNNC2;SPARCL1;MYL2;ESYT2;CASQ1;HRC;ATP2A2;ITPR1;FER1L5;PPP3CA;S100G;RASGRP2;DYSF;ASTN2;CDH13;SLC8A1;ANXA1;ASPH;LOXL2;ITSN1;LPL;LCP1;PADI2;STIM1;PITPNM3;CDH4;CAMKK2;SYT10;NUCB1;TESC;CDHR3
prerank,histone demethylase activity (GO:0032452),-0.5143357013250455,-1.6046174258009835,0.006097560975609756,0.4784334920481059,0.967,12/27,26.46%,KDM7A;KDM5C;KDM5B;KDM2A;KDM3B;JMJD6;RIOX2;KDM4D;KDM1A;KDM6A;FBXL19;HR
prerank,MAP kinase kinase kinase activity (GO:0004709),0.7725899637809857,1.6044417934717268,0.04788213627992634,0.37285682819533156,0.999,2/11,1.23%,MAP3K20;MAP3K5
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.5915466174982948,1.6029101055265729,0.017857142857142856,0.3673441973861336,0.999,17/72,11.78%,JPH2;OBSCN;HIP1;CGAS;MYO1B;MARK1;SYTL2;TTPA;PHLDA3;PLCB1;AMER1;PLCD1;ACTN2;SNX18;ANXA9;GRAMD2A;OSBPL2
prerank,alkali metal ion binding (GO:0031420),-0.6440088544695721,-1.6022413597922616,0.025821596244131457,0.4387007516676801,0.97,3/13,7.62%,ATP1A2;HDAC4;PDXK
prerank,sialyltransferase activity (GO:0008373),-0.5568238605643332,-1.5935037800770444,0.02956989247311828,0.4296353975154832,0.978,9/20,11.00%,ST3GAL4;ST3GAL6;ST8SIA4;ST3GAL1;ST3GAL5;ST6GALNAC3;ST8SIA1;ST3GAL3;ST8SIA2
prerank,gated channel activity (GO:0022836),-0.6154635680812258,-1.5922234716368482,0.02027027027027027,0.39764512708441646,0.978,9/14,25.67%,PIEZO1;PIEZO2;TMEM63A;TMC7;TMEM266;TMC4;TMC6;TMEM63B;PACC1
prerank,"DNA binding, bending (GO:0008301)",-0.6082421352858907,-1.5887876624727284,0.02493765586034913,0.3800948040776735,0.981,8/14,26.97%,LEF1;FOXD1;HMGB1;FOXL1;HMGA2;SAP30L;HHEX;HMGB2
prerank,R-SMAD binding (GO:0070412),-0.5725786248733026,-1.5881283496523282,0.026041666666666668,0.3545791806557926,0.981,10/18,18.22%,LDLRAD4;SMAD3;DDX5;SMAD6;RANBP3;RGCC;TRIM33;SMAD2;SMAD4;PMEPA1
prerank,damaged DNA binding (GO:0003684),-0.453102437242996,-1.583438301643077,0.011194029850746268,0.34473553575782145,0.985,27/44,36.07%,HMGB1;ERCC5;XRCC1;DDB1;NBN;EP300;CRY2;XPA;DCLRE1A;ERCC2;ERCC1;RAD1;ERCC4;DCLRE1B;HMGB2;OGG1;RPA3;TDG;SDE2;APTX;FANCG;RAD18;NEIL3;RPA2;ERCC3;DCLRE1C;RPA1
prerank,BMP binding (GO:0036122),0.7778864139592867,1.5807892447516,0.04891304347826087,0.4194678022058538,1.0,3/11,3.01%,TCAP;HJV;GREM2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.5657875040401877,1.5805733026372493,0.011547344110854504,0.4097151841748873,1.0,22/91,11.87%,JPH2;OBSCN;HIP1;CGAS;MYO1B;MARK1;TTPAL;KCNH1;SYTL2;TTPA;MAPT;CLVS1;PHLDA3;PLCB1;AMER1;PLCD1;ACTN2;SNX18;ANXA9;GRAMD2A;OSBPL2;WDR45
prerank,cation:chloride symporter activity (GO:0015377),-0.6827262357909613,-1.5795255994750506,0.0182648401826484,0.33456261400586884,0.989,5/10,18.20%,SLC12A2;SLC6A1;SLC12A7;SLC12A6;SLC12A8
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7773231401953998,1.5586246916046569,0.044722719141323794,0.46481466316695325,1.0,5/11,8.87%,SLC5A3;SLC2A10;SLC23A2;SLC23A1;SLC5A11
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5729013971036527,1.5575112032771288,0.02219482120838471,0.45772188664982033,1.0,8/73,5.49%,LHCGR;EDNRA;HCRTR1;CRHR2;EDNRB;VIPR2;TSHR;CYSLTR2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.6578986284473701,-1.554411796394662,0.04878048780487805,0.3889544608918725,0.997,4/10,12.38%,ANKRD13A;PML;FAN1;DNAJB2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.6329568840974148,-1.5462075577281689,0.03736263736263736,0.38935543786576116,0.997,7/12,21.48%,PIEZO1;PIEZO2;TMEM63A;TMC7;TMC4;TMC6;TMEM63B
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.5860470992823805,-1.5346426684350885,0.02736318407960199,0.40055024281829704,0.998,5/15,7.75%,ALDH1A2;ALDH1A1;ALDH3A2;ALDH4A1;ALDH7A1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.5508596729878448,1.5254195903796586,0.041044776119402986,0.553594454842844,1.0,14/75,10.96%,KCNAB1;HSD17B10;DHRS4;HIBADH;MDH1;ME3;HSD17B7;DHRS3;HSD17B4;LDHD;CBR1;HADHB;NSDHL;PTGR1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.6647029376589464,1.525308432974848,0.07142857142857142,0.541597407492011,1.0,6/22,13.12%,ATP2A1;ATP2A2;ATP6V0A2;ATP6V1C1;ATP2A3;ATP6V0D2
prerank,GABA receptor activity (GO:0016917),0.6607527432247667,1.5178568258232081,0.058823529411764705,0.5545924181246775,1.0,6/21,11.98%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,Wnt-activated receptor activity (GO:0042813),0.7021393994012187,1.5136334261124023,0.06879194630872483,0.5573752534756645,1.0,7/15,11.54%,FZD5;ROR1;FZD4;FZD8;FZD9;LRP5;TSPAN12
prerank,calcium-release channel activity (GO:0015278),0.7029481240034148,1.5134785894171752,0.08146964856230032,0.546273958167219,1.0,3/17,1.66%,RYR1;RYR2;ITPR1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.6488664904704606,-1.5104242451437353,0.033542976939203356,0.45923722913967974,1.0,4/10,12.38%,ANKRD13A;FAN1;DNAJC2;DNAJB2
prerank,ion gated channel activity (GO:0022839),0.637280863183699,1.5085682004612664,0.056162246489859596,0.5515942967724934,1.0,8/24,9.82%,ANO1;ANO6;TTYH1;KCNT2;ANO10;TRPM4;KCNT1;ANO3
prerank,sodium channel regulator activity (GO:0017080),0.6011091058480017,1.5055624543526296,0.06403269754768393,0.55019114813873,1.0,7/37,7.24%,FGF13;ATP2B4;FGF14;SNTA1;CAMK2D;NEDD4;PRSS8
prerank,lysine-acetylated histone binding (GO:0070577),-0.5325018848735259,-1.503851304475692,0.05191256830601093,0.43823755838983053,1.0,7/20,7.54%,MLLT3;CARM1;ATAD2B;BRD9;ZMYND8;TRIM24;BRDT
prerank,acetylation-dependent protein binding (GO:0140033),-0.5325018848735259,-1.503851304475692,0.05191256830601093,0.43823755838983053,1.0,7/20,7.54%,MLLT3;CARM1;ATAD2B;BRD9;ZMYND8;TRIM24;BRDT
prerank,intracellular chloride channel activity (GO:0061778),0.68964689949185,1.4956673933498725,0.057692307692307696,0.560821527547313,1.0,5/16,9.82%,ANO1;ANO6;TTYH1;ANO10;ANO3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.68964689949185,1.4956673933498725,0.057692307692307696,0.560821527547313,1.0,5/16,9.82%,ANO1;ANO6;TTYH1;ANO10;ANO3
prerank,NADP binding (GO:0050661),0.5956279255994051,1.4920790321380748,0.06069364161849711,0.5624502775350132,1.0,3/32,4.65%,KCNAB1;CRYZ;ME3
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.42381614360647335,-1.4908217681137705,0.022321428571428572,0.46118350399971186,1.0,19/51,18.57%,SLC22A8;SLCO2B1;SLCO1C1;SLCO2A1;SLC7A5;SLC25A3;MCU;SLC35E2A;SLC35E2B;SLC22A6;CLCN4;SLCO3A1;SLC25A14;SLC22A4;SLC5A5;SLC25A30;SLC25A11;SLC35D2;SLC35D1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.632544307593195,1.488656317044021,0.07526881720430108,0.5624389717125657,1.0,5/24,6.38%,MYLK2;CAMK2G;CAMK2D;PHKA2;MAPKAPK2
prerank,protein heterodimerization activity (GO:0046982),0.5014087072220828,1.487826154643706,0.013029315960912053,0.5547443410786499,1.0,38/178,11.59%,TPM2;TPM1;AGTR1;AOC3;MEF2C;RALGAPA2;UBA2;HIP1;PDGFB;ITGA3;NR4A1;FZD4;ITGB1;EXT2;BCL2;KCNB1;MEF2A;ATP1B1;SAE1;TAF1;TP53;TUBB2B;BCL2L2;FZD9;ADD2;RALGAPA1;TPM4;GCA;NR4A2;RALGAPB;DGKD;HIF1A;SRI;TOP2B;PDGFA;ATF3;ABCG1;BOK
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.7457891759453734,1.4857867056193976,0.0918918918918919,0.5515967981070515,1.0,2/11,3.36%,PADI3;PADI2
prerank,voltage-gated chloride channel activity (GO:0005247),0.7345259501409684,1.4856907170042966,0.0913884007029877,0.5421776937052115,1.0,3/10,5.96%,ANO1;ANO6;CLCN6
prerank,calcium channel regulator activity (GO:0005246),0.5976345386462005,1.4834227014344197,0.07746478873239436,0.5398456146055816,1.0,10/37,10.49%,PRKG1;ITPR1;INAFM2;PACSIN3;RRAD;STIM1;GEM;CALM1;SRI;REM1
prerank,glucose transmembrane transporter activity (GO:0005355),0.6586097874596168,1.48259203000423,0.09615384615384616,0.5334045918653213,1.0,4/17,8.87%,SLC2A4;SLC5A3;SLC2A10;SLC5A11
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.5926844481308776,-1.4687413841390582,0.04738154613466334,0.5145817361496637,1.0,7/13,17.61%,ALDH1A2;ALDH1A1;ALDH3A2;ALDH4A1;ALDH7A1;ADH5;ALDH1L1
prerank,phosphatidylglycerol binding (GO:1901611),-0.5695481633926104,-1.465076314494174,0.06971153846153846,0.5066426978965642,1.0,6/13,14.96%,PITPNA;PLTP;GSDME;PITPNC1;GSDMD;STOML2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6576375097429206,1.4647495753642554,0.10144927536231885,0.5806821495940706,1.0,5/18,9.06%,PDLIM1;PDLIM5;ANXA1;CNN3;PPP1CA
prerank,glucuronosyltransferase activity (GO:0015020),0.6572472240584892,1.4634085729074924,0.0784313725490196,0.5754224198286757,1.0,3/19,3.73%,LARGE1;CSGALNACT1;EXT2
prerank,androgen receptor binding (GO:0050681),-0.4681357906056562,-1.4538362678843497,0.05688622754491018,0.5257498205392567,1.0,11/25,19.27%,NSD1;PRKCB;FOXP1;DDX5;RNF6;PRMT2;SNW1;EP300;CALR;KDM1A;PARK7
prerank,metal ion binding (GO:0046872),0.4737768642743077,1.453728939660104,0.001004016064257028,0.5977711919866407,1.0,71/477,10.26%,ASPN;SLIT3;SLIT1;RYR1;ATP2A1;TTN;MAP3K20;CDH6;RYR2;AOC3;TNNC2;SPARCL1;STK38L;MAP3K5;MYL2;ESYT2;UBA2;CASQ1;HRC;DYRK2;ATP2A2;ITPR1;FER1L5;PPP3CA;S100G;ADCY2;RASGRP2;DYSF;ASTN2;CDH13;SLC8A1;ANXA1;ASPH;LOXL2;CSGALNACT1;ITSN1;LPL;LCP1;PADI2;STIM1;PITPNM3;GEM;CDH4;CAMKK2;SYT10;MARK1;NUCB1;TESC;CDHR3;TPPP;EML1;CALB1;CALM1;STK26;RASGRP1;OPA1;PAPOLA;PRKACB;DIS3L2;NCS1;TPM4;CDH2;TRPM4;GCA;BRSK1;AASDHPPT;TPD52;RAP2A;AGRN;SRI;AOAH
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5874912936655687,-1.4528235752706011,0.051643192488262914,0.510205820063858,1.0,6/12,14.29%,IGF1;ARRB1;GNAS;SOCS2;IGF2;INSR
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.5101312577471375,1.4493109657359535,0.05232558139534884,0.602912788272608,1.0,19/100,12.02%,JPH2;OBSCN;HIP1;FERMT2;MYO1B;TTPAL;KCNH1;TTPA;MAPT;DAB2IP;CLVS1;PHLDA3;ANKFY1;FCHSD2;GAP43;DENND1A;MYO10;WDR45;SNX13
prerank,potassium channel activity (GO:0005267),0.5080107625072914,1.447499172713981,0.05889281507656066,0.5994520182075606,1.0,18/89,11.35%,KCNMA1;TMEM38B;KCNMB1;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNB1;CCDC51;KCNH1;KCNT2;GRIK5;KCNT1;ABCC8;TMEM38A;KCNH8;KCNK3;KCNA2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5264446532403988,-1.4461171311901768,0.06082725060827251,0.5126692070541702,1.0,4/18,6.30%,ALDH1A2;ALDH1A1;FAR2;ALDH3A2
prerank,E-box binding (GO:0070888),-0.4422527479915695,-1.4457506268179139,0.0429042904290429,0.496210059773032,1.0,14/34,26.21%,TCF4;ZEB1;MAX;AHR;HES1;BHLHE41;PER1;BHLHE40;PPARG;ATOH8;TAL1;TFAP4;SNAI1;TWIST1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6765291254788667,1.4406481233422255,0.11428571428571428,0.6138225748753335,1.0,4/13,8.72%,RYR2;SOX9;PKIA;PRKAR1B
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6606342018553922,1.4395390650327835,0.12220309810671257,0.6082511920719136,1.0,2/14,6.78%,NCF2;KMO
prerank,death receptor binding (GO:0005123),0.6716121593111904,1.4389412949185783,0.09433962264150944,0.6011631317121288,1.0,3/15,6.25%,NTF3;MYD88;DAB2IP
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.5613411539758209,-1.4379818171523069,0.056372549019607844,0.506358479980496,1.0,9/14,31.81%,SLC7A11;SLC1A3;SLC17A6;SLC38A7;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6
prerank,hexose transmembrane transporter activity (GO:0015149),0.68268474084639,1.437490150338112,0.11091549295774648,0.5970376602017634,1.0,2/12,2.86%,SLC2A4;SLC5A3
prerank,transaminase activity (GO:0008483),0.7017064470312092,1.4329918705332039,0.10434782608695652,0.6023680531910461,1.0,3/11,7.85%,BCAT2;GOT1;GOT2
prerank,chemoattractant activity (GO:0042056),0.5940554908717104,1.429023716962791,0.11515151515151516,0.606299484093975,1.0,5/26,6.86%,NTF3;PDGFB;CCL5;VEGFA;GDNF
prerank,growth factor activity (GO:0008083),0.5145083308302728,1.4277200272274106,0.07535885167464115,0.6020688325124417,1.0,9/74,7.13%,NTF3;FGF1;PDGFB;THPO;JAG1;IL2;VEGFA;GDNF;AREG
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6786054163032763,1.4241916504744583,0.11896551724137931,0.6045878486484105,1.0,3/12,8.44%,TENT5B;PAPOLA;TENT4A
prerank,actin monomer binding (GO:0003785),0.6225065564976998,1.4213435023660317,0.12042682926829268,0.6048350315193246,1.0,5/22,3.40%,LMOD2;MYL2;LMOD3;MYL3;MRTFA
prerank,antiporter activity (GO:0015297),-0.5056877657255584,-1.417462484528078,0.07909604519774012,0.556807719126493,1.0,11/20,29.35%,SLC35E2A;SLC35E2B;CLCN4;SLC25A14;SLC25A30;SLC25A11;SLC35D2;SLC35D1;SLC35E3;SLC35E4;SLC35C2
prerank,phospholipase C activity (GO:0004629),0.6238680985330552,1.4161081765109855,0.12888198757763975,0.6131582245769014,1.0,7/25,9.48%,EDNRA;PLCE1;PLCB4;PLCL1;CCL5;PLCB1;PLCD1
prerank,motor activity (GO:0003774),0.5279647339740838,1.414116209758307,0.07770700636942675,0.6113104242899647,1.0,20/60,14.53%,MYO1E;MYL6;KIF27;MYH9;KIF2A;DYNLRB1;KIF3B;DNAH17;KIF1A;PIN1;KIF5B;CENPE;KIF1C;DYNC1I2;KIF5C;KIF5A;APPBP2;KIF20B;KIF18A;KIF6
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5267339986510482,-1.407469125856441,0.08333333333333333,0.5560840113937108,1.0,6/16,10.86%,PTPRB;PTPRG;PTPRN2;PTPRM;PTPRZ1;PTPRD
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5267339986510482,-1.407469125856441,0.08333333333333333,0.5560840113937108,1.0,6/16,10.86%,PTPRB;PTPRG;PTPRN2;PTPRM;PTPRZ1;PTPRD
prerank,cAMP response element binding (GO:0035497),-0.596746253103482,-1.4038532845941962,0.1038961038961039,0.5506467265574906,1.0,6/10,20.06%,CREB5;ATF2;CREB1;CREB3L1;ATF7;HMGA2
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.6065387382508768,1.4027148506633915,0.1228878648233487,0.6399332711182228,1.0,2/21,0.93%,RYR2;AKAP6
prerank,voltage-gated anion channel activity (GO:0008308),0.6530089960339632,1.4020881900452098,0.13432835820895522,0.6335707616421695,1.0,4/15,8.75%,ANO1;ANO6;CLCN6;VDAC1
prerank,microtubule plus-end binding (GO:0051010),0.6182461481105934,1.3989298591169954,0.12202852614896989,0.6352910034666701,1.0,11/20,17.37%,CLASP2;STIM1;DST;MAPRE2;CLIP3;FBXW11;CLASP1;KIF18A;MAPRE3;KNSTRN;DCTN1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5443196249312559,-1.3974618185937535,0.08411214953271028,0.5561857428619266,1.0,5/14,15.21%,ATXN3;MINDY3;OTUD7B;USP7;MINDY1
prerank,transforming growth factor beta binding (GO:0050431),0.6021522071007485,1.3968471795646193,0.11890243902439024,0.6339888903685922,1.0,5/23,3.63%,LTBP1;VASN;CD36;LRRC32;TGFB3
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.38391589950056193,-1.393980477050336,0.06986899563318777,0.5525496681284875,1.0,26/53,30.26%,SLC7A11;SLC1A3;SLC47A1;SLC3A2;SLC7A5;CTNS;SLC6A9;SLC43A2;SLC17A6;SLC66A1;SLC38A5;SLC38A6;SLC25A38;SLC38A7;SLC7A7;SLC15A4;SLC1A4;SLC36A1;SLC43A1;SLC1A1;SLC25A22;SLC1A2;SLC25A15;SLC7A6;SLC25A18;SLC38A9
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6013317052866878,-1.3929423274557962,0.07223476297968397,0.5413255272879351,1.0,5/10,8.85%,SLCO2B1;SLCO1C1;SLCO2A1;SLC22A6;SLCO3A1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.6150436277832364,1.3921542807455893,0.1494435612082671,0.6402693583284127,1.0,3/21,5.14%,PDE3A;PDE5A;PDE4A
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5542539778995743,1.3869042716562991,0.11231393775372124,0.6484768515392444,1.0,3/38,3.37%,SERPINB8;SERPINI1;SERPINE2
prerank,chemorepellent activity (GO:0045499),-0.45882659459619596,-1.3836110767749943,0.09037900874635568,0.5555657589793609,1.0,9/25,13.75%,SEMA3D;EPHA7;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D;DPP4
prerank,protein homodimerization activity (GO:0042803),0.4469686589080343,1.3785895425984005,0.003003003003003003,0.6665883334407328,1.0,119/589,15.02%,MYOM1;TPM2;SOX6;PLN;FLNA;TPM1;ATP2A1;RBPMS;ACTN1;RBPMS2;TRPC6;CAMK2G;ACTN4;MAP3K5;RBM44;MYOM3;ANO1;CHMP4C;HIP1;HSPB6;PDGFB;SYNE1;PDGFC;MYH9;PIP4K2A;MYO9B;CAMK2D;FZD4;LPL;PADI2;CCL5;ACP3;EXT2;NACC2;KCNN2;NR2F2;BCL2;BMPR1A;TBX18;LHPP;TYW5;ATG7;TESC;HSD17B4;ZDHHC2;CRPPA;TPPP;DAB2IP;TERT;VEGFA;GRHL1;ZBTB38;GDNF;SFPQ;STK26;PLEK;BCL2L2;FZD9;GLA;ADD2;TGFB2;RELA;MAP3K10;DAPK3;TRIM68;TPM4;MVD;GCA;MGLL;LRRFIP1;PTH1R;DGKD;HOOK1;TPD52;ST6GAL1;RAB11FIP3;RAB11FIP4;DNM1L;S100A6;PDGFA;GGCT;ATF3;TERF2;ABCG1;BOK;DUSP29;TSG101;GSTA4;AIMP1;GBP2;DROSHA;CHRNA7;KIF20B;SNX9;NR6A1;PDCD10;POU3F3;HPS4;ST3GAL2;CEP43;TMEM192;MKLN1;PDK2;MTCL1;DGCR8;STK10;MCL1;ZBTB4;EPRS1;HM13;SPPL2B;LRRK2;TNNC1;GLB1;KNSTRN;MLXIPL;KARS1;SNX1;EXD2
prerank,fatty acid synthase activity (GO:0004312),-0.5884109403464497,-1.3777873996737522,0.12554112554112554,0.5592374098996353,1.0,7/10,34.40%,ELOVL7;ELOVL4;ELOVL6;ELOVL1;OXSM;ELOVL5;MCAT
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5811700663111052,-1.3725164185771923,0.10580912863070539,0.5621535763696126,1.0,7/10,36.38%,B4GALT1;B4GALT6;B4GALT7;B3GALT2;B3GALT1;A3GALT2;B3GALT6
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.6681934824534996,1.372217306021154,0.149812734082397,0.6791363212516299,1.0,2/12,5.14%,PDE3A;PDE4A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.6066809202895621,1.3653085320388554,0.13428120063191154,0.6927396032221499,1.0,6/23,9.48%,EDNRA;PLCE1;PLCB4;CCL5;PLCB1;PLCD1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.576017752791327,1.3634171600653744,0.13656387665198239,0.6908766092432085,1.0,9/27,10.32%,ATP2B4;CNNM2;ITPR1;SLC8A2;SLC4A8;ATP2B1;SLC23A1;MRS2;ATP2A3
prerank,mannose binding (GO:0005537),0.6419168036867517,1.360302109309859,0.17086330935251798,0.6932298647955556,1.0,2/12,7.73%,CLN5;MBL2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5554120512235229,-1.3584574000131846,0.12244897959183673,0.5935606282861147,1.0,5/12,18.12%,PIK3CA;PIK3R3;PIK3CB;PIK3R6;ATM
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.5893672186207858,1.3577640153366384,0.16043613707165108,0.6940751433703929,1.0,3/23,5.14%,PDE3A;PDE5A;PDE4A
prerank,Toll-like receptor binding (GO:0035325),0.6518182825660155,1.3537491968665976,0.18685121107266436,0.6992244267612879,1.0,3/11,6.25%,CD36;MYD88;DAB2IP
prerank,ankyrin binding (GO:0030506),0.604899960163449,1.3512773112099332,0.14622641509433962,0.699586739578815,1.0,3/19,4.31%,OBSCN;SLC8A1;FLNC
prerank,ligand-gated anion channel activity (GO:0099095),0.5971310282371258,1.351167466921123,0.15307820299500832,0.6921186052291696,1.0,6/17,11.98%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1;GABRB3
prerank,FMN binding (GO:0010181),-0.5620639272795018,-1.3509921438510613,0.1228813559322034,0.6042106482268271,1.0,3/11,9.33%,POR;PPCDC;NOS3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.581016599763228,1.349664018912152,0.14014598540145987,0.6889845228192518,1.0,6/25,9.76%,OBSCN;HIP1;TTPA;PHLDA3;PLEK;FCHSD2
prerank,solute:anion antiporter activity (GO:0140323),-0.5254436881227413,-1.348464255409012,0.12158808933002481,0.5985503566522662,1.0,4/14,11.16%,SLC7A11;SLC26A7;SLC4A2;SLC26A2
prerank,bHLH transcription factor binding (GO:0043425),-0.4906305751138895,-1.3460679673494214,0.13823529411764707,0.5926274402362911,1.0,9/19,26.21%,SMAD3;FHL2;PSMD9;BHLHE41;BHLHE40;KDM1A;LMO2;USF1;TWIST1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.4340735313679158,-1.3421331301972481,0.10561056105610561,0.5932529087101218,1.0,15/29,31.81%,SLC13A3;SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC26A6;SLC25A21;SLC25A18;SLC13A5;SLC1A6
prerank,metalloaminopeptidase activity (GO:0070006),0.6196084069370118,1.3397069116148441,0.1557377049180328,0.7127976962906148,1.0,4/16,7.40%,MMP17;LNPEP;RNPEP;ENPEP
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5560073609630523,-1.3385622636237486,0.1348314606741573,0.5910029757902395,1.0,2/11,0.83%,SRRM2;LEF1
prerank,solute:sodium symporter activity (GO:0015370),0.5671326100615097,1.3382216788342127,0.15781710914454278,0.7096035470213391,1.0,5/27,8.87%,SLC5A3;SLC4A8;SLC20A2;SLC4A7;SLC5A11
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.667876683524423,1.3323787481099412,0.1902071563088512,0.7206949440035771,1.0,3/10,7.01%,PRDM16;SUV39H2;ASH1L
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.512559043992625,-1.329171096320599,0.12439024390243902,0.6073443356437773,1.0,5/14,17.16%,SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11
prerank,voltage-gated potassium channel activity (GO:0005249),0.4730864968273535,1.3271119107015925,0.12934131736526946,0.7299840008565542,1.0,12/80,9.71%,KCNMA1;KCNJ12;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNE4;KCNB1;KCNH1;KCNT2;KCNT1;KCNH8
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.47950529048525403,-1.325672957595144,0.13123359580052493,0.5930590916145452,1.0,8/17,22.01%,EPHA7;EPHA4;EPHA3;EPHA8;EPHA10;EPHB4;EFNB3;EPHB2
prerank,ephrin receptor activity (GO:0005003),-0.47950529048525403,-1.325672957595144,0.13123359580052493,0.5930590916145452,1.0,8/17,22.01%,EPHA7;EPHA4;EPHA3;EPHA8;EPHA10;EPHB4;EFNB3;EPHB2
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6272750275352639,1.3204748448265193,0.17943925233644858,0.7429709869306681,1.0,7/13,10.74%,PDGFB;PDGFC;PDGFD;VEGFA;ITGB3;PDGFRB;PDGFA
prerank,sodium channel activity (GO:0005272),0.5218820595820068,1.3203788080050705,0.15285714285714286,0.7356450722596793,1.0,3/37,1.95%,SCN4A;ASIC3;CACNA1H
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.33467022094678556,-1.3166307410778244,0.045454545454545456,0.6104168979829223,1.0,12/71,5.83%,EYA2;PTPN13;EYA1;PTPRB;EYA4;PTPRG;PTPN14;CDC14B;PTPN11;PTPRN2;PTPRM;PTPRZ1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5468843046335593,-1.3163210168489823,0.14446952595936793,0.5996916474399878,1.0,4/11,3.69%,SLC6A13;SLC1A3;SLC6A1;SLC6A12
prerank,leak channel activity (GO:0022840),-0.482435908254887,-1.3150206281291716,0.13231552162849872,0.5922384160547378,1.0,3/18,6.55%,KCNK2;NALCN;KCNK5
prerank,glutamate receptor activity (GO:0008066),-0.4766911505267755,-1.3133191102735788,0.12686567164179105,0.5862239759860057,1.0,7/19,19.56%,GRM3;GRM7;GRIK3;GRIN2D;GRM5;GRID2;GRIK1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5656826946591905,-1.310209952175282,0.14347826086956522,0.5840716687113882,1.0,3/10,7.39%,PIK3CA;PIK3R3;PIK3CB
prerank,cholesterol binding (GO:0015485),-0.37900269777362616,-1.3082621195501902,0.08979591836734693,0.5789348797676184,1.0,17/47,23.59%,OSBPL8;ABCA1;PTCH1;OSBPL10;GRAMD1C;ANXA6;APOD;SCARB2;SIDT1;PROM1;SOAT1;GRAMD1A;STARD4;SYP;STARD3NL;STARD5;NPC1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5790359096858175,1.3080292424306164,0.1806020066889632,0.7678296666590728,1.0,5/19,9.21%,GABRE;GABRA4;GABRA5;GRIK5;GABRG1
prerank,hyaluronic acid binding (GO:0005540),-0.5617885509808536,-1.306163523956893,0.15883668903803133,0.5750956421905744,1.0,4/10,14.43%,CEMIP;CD44;LAYN;IMPG2
prerank,histone acetyltransferase binding (GO:0035035),0.5662584956505166,1.3033664332619763,0.19478527607361965,0.7751382125140309,1.0,11/21,20.78%,MEF2A;TP53;TRIM68;HIF1A;SIRT2;ZBTB7A;CITED2;KANSL1;STAT1;EGR1;KANSL1L
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.5476410086424155,1.3015591132229358,0.17008797653958943,0.7730640594089278,1.0,6/27,8.16%,ASIC3;SLC8A2;SLC8A1;SLC4A8;SLC23A1;SLC9A8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.3577179231111644,-1.2996388416918474,0.07772020725388601,0.5835588521890287,1.0,19/54,19.80%,NGLY1;ASPA;ACER2;NAAA;HDAC4;PIGL;SIRT7;HINT1;ASAH2;SUDS3;UPB1;ASRGL1;NTAQ1;ASPG;HINT3;HDAC2;NADSYN1;AMDHD2;MIER1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4799329827625102,-1.2983226193500321,0.1329923273657289,0.5775312835294621,1.0,11/16,31.81%,SLC13A3;SLC25A14;SLC25A30;SLC25A11;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC25A18;SLC13A5;SLC1A6
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.5305395251141356,-1.2980643917473118,0.16515837104072398,0.5684475815334725,1.0,8/11,36.44%,SLC25A17;SLC35B3;LRRC8A;SLC25A24;SLC35B2;SLC17A9;SLC25A25;SLC19A1
prerank,GTPase inhibitor activity (GO:0005095),-0.514925727177608,-1.2967674517575878,0.16166281755196305,0.5627861345364716,1.0,3/13,3.94%,CPEB2;SLIT2;PDE6D
prerank,ATPase activator activity (GO:0001671),-0.46023580923004004,-1.2962221605718585,0.14794520547945206,0.5553329430029523,1.0,7/20,12.41%,ATP1B3;DNAJC10;TOR1AIP2;TOR1AIP1;ATP1B2;DNAJB2;DNAJC19
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5342176660739573,1.286885068113387,0.1796042617960426,0.8141060400524557,1.0,8/28,16.82%,GABRE;GABRA4;GABRA5;GRIK5;GABRG1;CHRNA7;CHRNA4;GRIK4
prerank,kinase binding (GO:0019900),0.4157692243454655,1.2863717806051054,0.03819095477386935,0.8079126210843619,1.0,60/434,11.36%,MYOM1;ACTA2;FLNA;ARHGEF7;TTN;PPP1R12A;INKA2;MYOM2;PRKAB2;LIMS1;CCNA2;FERMT2;FZD5;CCND2;CSPG4;FAM83D;KCNA5;BCAR3;RHOBTB3;LAX1;PARN;TSKS;ACTB;UTRN;DOK7;LYST;CAV1;MAPT;DAB2IP;DUSP3;TP53;PPP2R5A;PARP1;PTPN1;CALM1;TPX2;BTG1;RAD9A;ADD2;RELA;TRIM68;CCND1;RHOF;VDAC1;PPP1CB;SKI;PAK2;TOM1L2;ADCY6;DGKD;HIF1A;CEP192;PDGFRB;GYS1;ANKRA2;RB1;PFKM;PRKCD;UNC5C;RHOH
prerank,receptor antagonist activity (GO:0048019),0.5741516483740232,1.2863000775581408,0.2365415986949429,0.8002782413576189,1.0,3/17,6.02%,FST;CCL5;PXDN
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6020737468406473,1.2832992091011293,0.1978798586572438,0.8027844702373513,1.0,4/13,9.21%,GABRE;GABRA4;GABRA5;GABRG1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.46859368512897126,1.2824428928735054,0.16034271725826194,0.7978003238240546,1.0,7/74,4.76%,DGKB;DGKG;NMRK2;FAM20A;HK2;GNE;ADPGK
prerank,DNA-binding transcription factor binding (GO:0140297),0.4328666980907851,1.2769393946458543,0.1044932079414838,0.808589338039736,1.0,26/189,9.18%,MYOCD;PRDM16;MEF2C;HEY2;CRTC1;GABPA;PRRX1;RUNX1T1;TEAD3;CRTC3;HDAC9;ANKRD2;BCL2;PIAS4;MEF2A;MTDH;TAF1;TP53;AR;YAP1;RELA;MAP3K10;DAPK3;PPARA;MTA3;SKI
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.509816004629525,-1.2758856421039466,0.16856492027334852,0.6022076738155115,1.0,8/12,36.44%,SLC25A17;SLC35B3;LRRC8A;SLC25A24;SLC35B2;SLC17A9;SLC25A25;SLC19A1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4281567852154518,1.2689934364715258,0.11416490486257928,0.8262052982850704,1.0,29/181,11.65%,MYOCD;HEY2;ACTN4;SMARCD3;NR1H4;PRRX1;TEAD3;ARID1A;ANKRD2;ACTB;PIAS4;SETD6;MEF2A;NCOA7;MTDH;TAF1;SMARCB1;TP53;AR;PPARGC1A;MED1;RELA;PPARA;MTA3;HIF1A;RB1;TACC2;PIAS2;BAZ2A
prerank,calcium channel inhibitor activity (GO:0019855),0.6322714250588778,1.2686156173388978,0.22426470588235295,0.8197990609964414,1.0,3/11,7.02%,ITPR1;PACSIN3;CALM1
prerank,water transmembrane transporter activity (GO:0005372),-0.5341835610003816,-1.2660625395971634,0.17312072892938496,0.6222094657339323,1.0,1/11,1.63%,PDPN
prerank,I-SMAD binding (GO:0070411),-0.5020609247174141,-1.2571863300491133,0.215962441314554,0.6392628501687507,1.0,7/13,17.38%,SMAD3;SMAD6;SMAD9;CTNNB1;TGFBR1;SMAD2;SMAD4
prerank,receptor tyrosine kinase binding (GO:0030971),0.4720688364066935,1.256312428461069,0.19041614123581338,0.8537567964913977,1.0,10/56,6.82%,ANGPT2;ANGPT1;ANGPT4;SOCS5;PITPNM3;ARHGEF16;IRS1;DUSP3;TP53;PTPN1
prerank,carboxy-lyase activity (GO:0016831),-0.4332204919426387,-1.255203677629803,0.18328840970350405,0.635395013601057,1.0,9/23,21.19%,PPCDC;UXS1;ECHDC1;AMD1;PCK2;AZIN1;DDC;ODC1;GAD1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.505900406451293,-1.2543022716384165,0.1935483870967742,0.6280522730677383,1.0,9/12,44.78%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,regulatory RNA binding (GO:0061980),-0.36887723524956995,-1.2533103905834333,0.1413427561837456,0.6218909418329874,1.0,17/38,34.50%,AGO3;PUM1;MATR3;ZC3H7A;TUT4;PNPT1;ZC3H12A;FMR1;TUT7;ZC3H7B;YBX1;RBM10;AGO4;ZC3H10;HNRNPA2B1;ELAVL1;SPOUT1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.4442480664768235,-1.2530772773085685,0.1794871794871795,0.613448895565311,1.0,7/20,15.28%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,glycine binding (GO:0016594),-0.5202663452749238,-1.2530086378443879,0.21330275229357798,0.6048145198027788,1.0,5/11,20.84%,GLRB;GRIN3A;GLRA2;SRR;GLRA1
prerank,voltage-gated sodium channel activity (GO:0005248),0.5480582124511691,1.2524808141466828,0.22136222910216719,0.8590095873809708,1.0,2/22,1.95%,SCN4A;CACNA1H
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5588476834342361,1.2503871902786934,0.2471169686985173,0.8586732703507622,1.0,4/18,5.14%,HJV;LTBP1;ACVR2A;BMPR1A
prerank,transferrin receptor binding (GO:1990459),0.6304703040074119,1.2502714015772356,0.25359712230215825,0.8514092595864993,1.0,1/10,0.59%,HJV
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5334328505284431,-1.2497996638044386,0.17248908296943233,0.6048791049980676,1.0,7/11,38.52%,CASP8;CASP9;CASP4;CASP12;CASP6;PYCARD;CASP1
prerank,protein kinase C activity (GO:0004697),-0.48830398079721027,-1.2476324773848386,0.18925233644859812,0.6020860227144806,1.0,4/14,7.71%,PRKCB;PRKCH;SMG1;PRKCE
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5112984676946408,-1.2445980783702166,0.21016166281755197,0.6022444775385797,1.0,6/12,21.66%,SLC6A6;SLC3A2;SLC38A5;SLC38A7;SLC1A4;SLC36A1
prerank,sterol transfer activity (GO:0120015),-0.4594543936309939,-1.2438163542202714,0.208955223880597,0.5958320462311415,1.0,7/17,23.46%,PLTP;ABCA1;GRAMD1C;GRAMD1A;STARD4;OSBP;STARD5
prerank,chloride channel inhibitor activity (GO:0019869),-0.5331061112971632,-1.2409098922036732,0.2040358744394619,0.5957756471675102,1.0,6/10,17.84%,WNK1;WNK4;WNK3;STX1A;VAMP8;STX8
prerank,ADP binding (GO:0043531),0.5239948391205563,1.240859682554143,0.22652757078986588,0.8753034682428167,1.0,8/25,11.57%,ACTA1;MYH9;MYO9B;MYO18A;COQ8A;MIEF1;LONP1;ABCG1
prerank,potassium ion leak channel activity (GO:0022841),-0.473064104742351,-1.2392156163442558,0.20681818181818182,0.5921021727572604,1.0,2/15,6.55%,KCNK2;KCNK5
prerank,SH2 domain binding (GO:0042169),0.505088831227952,1.2357003154964312,0.21897810218978103,0.8857994501811445,1.0,7/31,11.25%,DLC1;LAX1;NUP62;IRS1;INPPL1;PAG1;ARHGAP5
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5063159885235069,1.2351493723674356,0.2276657060518732,0.8800834714248478,1.0,6/32,5.58%,KCNQ5;KCNA5;KCNQ4;KCNE4;KCNB1;KCNH1
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.2919564976451142,-1.2326459484690035,0.06896551724137931,0.6023030055112403,1.0,27/134,9.92%,SLC6A13;SLC16A12;SLC1A3;SLC13A3;ABCG2;PDPN;GJA1;SLCO2B1;SLC6A1;SLC6A6;SLC26A7;SLC16A1;SLCO1C1;SLC25A17;SLCO2A1;SLC3A2;SLC25A32;SLC52A1;SLC7A5;SLC39A8;CTNS;SLC22A6;SLC16A11;SLC6A9;SLCO3A1;ABCC4;SFXN2
prerank,acid-thiol ligase activity (GO:0016878),0.5853683864271811,1.2298893283913168,0.2746478873239437,0.8899938114461792,1.0,1/13,0.89%,ACSS1
prerank,aminopeptidase activity (GO:0004177),0.5255404357202941,1.2285855876759926,0.228310502283105,0.8869460403386505,1.0,5/26,7.40%,MMP17;LNPEP;RNPEP;BLMH;ENPEP
prerank,adenylyltransferase activity (GO:0070566),0.54279814183242,1.2283930779356491,0.23672230652503792,0.8800776908904523,1.0,7/21,14.97%,NMNAT2;PAPOLA;TENT4A;NMNAT1;COASY;OASL;KARS1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.38149468908075385,-1.2276002655115803,0.17295597484276728,0.6082821576516556,1.0,14/32,22.84%,SLC6A6;SLC3A2;SLC7A5;SLC6A9;SFXN2;SLC43A2;SLC38A5;SLC38A6;SLC25A38;SLC38A7;SLC1A4;SLC36A1;SLC43A1;SLC1A1
prerank,CXCR chemokine receptor binding (GO:0045236),-0.5169603678283283,-1.2269549400725575,0.20638297872340425,0.6020434009172212,1.0,2/11,8.89%,ITCH;YARS1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5508755469913308,1.2252659395524346,0.2464,0.8828498578843568,1.0,2/18,4.70%,HSD17B10;HSD17B7
prerank,endopeptidase inhibitor activity (GO:0004866),0.44376766891035746,1.2248194274452515,0.19691577698695137,0.8768900212195265,1.0,7/82,6.81%,SERPINB8;SERPINI1;ROCK1;ITIH4;SERPINE2;LXN;TIMP4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.60308151167444,1.224230842601578,0.2685025817555938,0.8714824900881765,1.0,6/12,21.18%,TAF1;RELA;STAT1;HDAC1;POU2F1;H3-3A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.4947745666212372,-1.2241622756089992,0.23373493975903614,0.6014907530943394,1.0,4/12,17.73%,KDM7A;KDM3B;KDM4D;KDM1A
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5258196314068624,1.2212978306408349,0.23952095808383234,0.8739595697328068,1.0,5/25,9.92%,ART1;SIRT3;PARP1;ART4;SIRT2
prerank,WW domain binding (GO:0050699),0.5178027705279974,1.2208492138441094,0.21651090342679127,0.8683369496968237,1.0,7/26,19.99%,ENAH;WBP1;KIF20B;TCEAL3;TCEAL6;TCEAL9;NDFIP2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.526264569652521,-1.220688450591928,0.2359081419624217,0.6035254800363057,1.0,6/10,38.52%,CASP8;CASP9;CASP4;CASP12;CASP6;CASP1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4469485517500227,1.2174195159378516,0.24238733252131547,0.8722702284253974,1.0,10/60,10.19%,LRRC2;CAMK2G;PPM1L;PPM1J;PPP3CA;PPM1E;PPM1A;PPP1CB;PPP1CA;CTDSP2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5193770289186531,-1.2153696445887385,0.20920502092050208,0.6106192138978832,1.0,3/10,12.77%,KDM7A;KDM2A;RIOX2
prerank,gamma-tubulin binding (GO:0043015),0.5381919997623329,1.2142989600187741,0.28129829984544047,0.8754110654730862,1.0,4/21,9.13%,ARHGEF7;TUBGCP6;NDRG1;BRSK1
prerank,lipoprotein particle binding (GO:0071813),0.5470056147967459,1.214056228966493,0.2630744849445325,0.8692337696481753,1.0,4/20,6.17%,CD36;CDH13;LPL;MAPT
prerank,5'-3' exonuclease activity (GO:0008409),-0.4799597423631861,-1.21260230635712,0.23627684964200477,0.6100709670749653,1.0,7/14,25.84%,MRE11;FAN1;TRIR;DCP2;DCLRE1A;DCLRE1B;EXOG
prerank,chloride channel activity (GO:0005254),0.44629437949509543,1.2112092585450656,0.22807017543859648,0.8713994132913293,1.0,11/59,11.98%,ANO1;GABRE;ANO6;CLCN6;GABRA4;TTYH1;GABRA5;GABRB2;GABRG1;ANO3;GABRB3
prerank,carbohydrate kinase activity (GO:0019200),0.5972669189937779,1.2092141365900213,0.29856115107913667,0.8708807421213349,1.0,3/11,7.54%,HK2;GNE;FGGY
prerank,sequence-specific mRNA binding (GO:1990825),0.6025660312421451,1.20862864291668,0.27472527472527475,0.8660527701370087,1.0,1/10,0.82%,RBM24
prerank,microtubule binding (GO:0008017),0.4025694796782704,1.207425393862903,0.17121848739495799,0.8631017287377327,1.0,71/222,18.90%,FGF13;KIF27;CLASP2;FAM83D;HOOK2;KIF2A;STIM1;MAP1B;TOGARAM2;HAUS8;DST;KIF3B;MAP7D3;ARHGEF2;CEP290;MAPRE2;TUBGCP6;KIF1A;MAPT;NDRG1;TPPP;EML1;EML5;HDGFL3;TPX2;RMDN3;TOGARAM1;OPA1;KIF5B;SUN2;WHAMM;CCDC170;HOOK1;CENPE;CCDC181;KIF1C;DNM1L;FHDC1;KIF5C;CLIP3;FBXW11;KIF5A;KIF20B;CLASP1;MAST1;MTCL1;MAP4;KIF18A;HAUS7;LRRK2;KIF6;MAPRE3;UXT;KNSTRN;DNM2;CCDC66;ABRAXAS2;MAP9;GAS2L3;KIF7;S100A8;S100A9;STARD9;DCTN1;SGIP1;MAP1A;MAP1S;MAP6;CEP295;HAUS4;HDAC6
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5697301993356961,1.2038631723245985,0.27721088435374147,0.8672914356283471,1.0,3/15,15.00%,PLA2G3;PLA2G4A;PLA2G4C
prerank,tau-protein kinase activity (GO:0050321),0.5294375832710811,1.1974270574003512,0.2686335403726708,0.8801458037592792,1.0,5/20,10.88%,ROCK1;MARK1;DYRK1A;BRSK1;ROCK2
prerank,CoA-ligase activity (GO:0016405),0.5605780782773306,1.196021179237847,0.2849740932642487,0.8780769088556949,1.0,1/14,0.89%,ACSS1
prerank,Hsp70 protein binding (GO:0030544),-0.3829083535235497,-1.195427854521482,0.19879518072289157,0.6483601150577406,1.0,8/31,14.15%,DNAJB12;DNAJC10;PRKN;DNAJC2;STUB1;ERN1;DNAJB2;SNCA
prerank,protein serine/threonine kinase activity (GO:0004674),0.3893442453046508,1.1942056733142232,0.1292929292929293,0.8771584455287468,1.0,81/334,17.80%,MYLK2;MYLK;TTN;MAP3K20;MYLK4;CAMK2G;STK38L;MAP3K5;ROCK1;MAST4;KALRN;PRKAB2;DYRK2;CDK6;FAM20A;CAMK2D;ACVR2A;MARK1;BMPR1A;DYRK1A;PRKCQ;MAP4K3;MAP4K5;TAF1;RPS6KA2;MAPKAPK2;DYRK1B;CHEK1;NUAK1;MAP3K10;WNK2;DAPK3;MAP2K1;BRSK1;PKN2;PAK2;CDK7;STK33;STK24;EIF2AK2;ROCK2;PRKCD;ACVR1B;CDK12;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;STK36;PRKD3;TAOK3;CDK15;MAST1;CPNE3;CSNK1E;SGK1;STK10;MAPK1;LRRK2;PRKAA2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1;RAF1;PLK4;HIPK2;MAST3;ATP23;MAP3K13;EIF2AK3;CDK14;MAP3K2;MARK2;BRD4;MASTL;EIF2AK4;STK35;DAPK2
prerank,pentosyltransferase activity (GO:0016763),0.4758559773286952,1.192568576580175,0.265474552957359,0.8756362226401319,1.0,8/36,13.71%,ART1;LARGE1;SIRT3;PARP1;ART4;SIRT2;PPAT;SIRT4
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.24037217916143708,-1.1921145635351438,0.0,0.6493809956019488,1.0,98/346,19.46%,RNF220;TTC3;KCMF1;RNF145;NEDD4L;SH3RF1;TRIP12;FBXL5;RNF146;AREL1;ITCH;RNF38;FBXO10;CUL3;SEL1L;RNF185;MYCBP2;RNF20;PPIL2;UBE2D3;RNF135;BIRC6;RC3H2;RNF144B;SHPRH;RNF217;TRIM24;RNF6;PML;UBR2;BIRC2;RNF25;RNF13;FBXO9;HERC2;LTN1;RNF213;MDM2;PELI1;FBXO4;TOPORS;UBE2E2;CDC23;UBE2E3;FBXO7;RBCK1;TRIM25;WWP1;SH3RF3;SMURF2;RNF144A;RNF31;PRKN;UBE3A;MGRN1;FBXO25;MKRN2;RMND5B;RNF181;TRIM5;FBXO3;RNF34;STUB1;RMND5A;DZIP3;DTX1;VPS18;TRIM14;RNF125;DTX3L;RNF166;FBXW8;SH3RF2;SIAH1;UBE2H;RNF115;HECW1;BIRC3;RNF10;OBI1;NHLRC3;RNF43;TRIM56;DTX3;BCOR;CDC42;UBE2S;ANAPC4;UBA7;SIAH2;SYVN1;RNF130;CHFR;NEURL2;RNFT1;ARIH1;RNF41;BTRC
prerank,transmitter-gated ion channel activity (GO:0022824),0.48147683971545624,1.1890634697052898,0.26251896813353565,0.8805818831267116,1.0,7/29,11.98%,GABRE;GABRA4;GABRA5;GRIK5;GABRB2;GABRG1;GABRB3
prerank,ribosomal large subunit binding (GO:0043023),-0.4930534498414111,-1.1888343374098924,0.23787528868360278,0.6502188238818937,1.0,4/11,13.62%,CPEB2;NMD3;LTN1;NEMF
prerank,cholesterol transfer activity (GO:0120020),-0.44323752569333297,-1.1866846162883429,0.24213075060532688,0.6481837037364928,1.0,5/16,17.17%,PLTP;ABCA1;GRAMD1C;GRAMD1A;STARD4
prerank,tubulin binding (GO:0015631),0.38916878829221613,1.1853939455906006,0.1688708036622584,0.8854410299836066,1.0,78/295,17.50%,ARHGEF7;FGF13;AGBL1;DLEC1;KIF27;CLASP2;FAM83D;HOOK2;KIF2A;TTLL7;MAP1B;TOGARAM2;HAUS8;DST;KIF3B;PRUNE1;MAP7D3;ARHGEF2;GABARAP;MAPRE2;TUBGCP6;KIF1A;MAPT;NDRG1;TPPP;RABGAP1;IFT81;EFHC1;EML1;EML5;HDGFL3;TPX2;RMDN3;TOGARAM1;OPA1;KIF5B;SUN2;WHAMM;CCDC170;WASHC1;BRSK1;HOOK1;CENPE;CCDC181;KIF1C;DNM1L;NCALD;ALDOA;FHDC1;TBCD;KIF5C;UNC5C;CLIP3;KIF5A;KIF20B;CLASP1;MAST1;MTCL1;MAP4;KIF18A;STMN2;LRRK2;KIF6;MAPRE3;UXT;DNM2;CCDC66;ABRAXAS2;MAP9;GAS2L3;INO80;KIF7;S100A8;S100A9;STARD9;DCTN1;SGIP1;MAP1A
prerank,histone deacetylase binding (GO:0042826),0.42239341436261857,1.1852000452842286,0.24311926605504589,0.8796997884543564,1.0,21/88,14.12%,MEF2C;HEY2;GMNN;NACC2;PRDM1;HDAC9;MEF2A;TP53;SFPQ;RAD9A;RELA;CCND1;MTA3;PKN2;SIRT2;TOP2B;ANKRA2;KPNA2;CHD4;MEF2B;MTA1
prerank,protein phosphatase binding (GO:0019903),0.41000208748129646,1.1835112233314822,0.233751425313569,0.8783512240888484,1.0,13/117,7.70%,MYOZ2;ATP2B4;PPP1R3A;MAP3K5;ITGA1;STRN3;MFHAS1;AKAP11;MAPT;DAB2IP;TP53;TRAF3;ENSA
prerank,kinase activity (GO:0016301),0.41520076443084936,1.1815044777757948,0.23148148148148148,0.8782055564414983,1.0,21/109,14.40%,DGKB;DGKG;CKM;NMRK2;CKMT2;SEPHS2;ADPGK;SEPHS1;TAF1;COQ8A;PSTK;PKN2;DGKD;ITPKC;COASY;PRKD3;PIK3C3;DGKZ;CHKB;CKB;LRRK2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.586379893293098,1.1788364845738952,0.32287822878228783,0.8798700118683727,1.0,2/11,1.66%,TRPC6;ITPR1
prerank,beta-tubulin binding (GO:0048487),0.4825055640566961,1.1783913626449474,0.27601156069364163,0.8750754779735438,1.0,4/31,5.50%,FGF13;DLEC1;TTLL7;GABARAP
prerank,protein tyrosine kinase activity (GO:0004713),0.40781392868426836,1.1759996731565183,0.24287343215507412,0.8764299867291433,1.0,11/108,5.45%,TTN;NTRK3;DYRK2;MERTK;MST1R;ROR1;FRK;MUSK;CAMKK2;PEAK1;DYRK1A
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.4376720047222232,-1.1759687517292872,0.2401129943502825,0.6698005144817902,1.0,7/18,11.77%,TGFBR3;SMAD3;SMAD6;ENG;FKBP1A;TGFB1;TGFBR1
prerank,MHC class I protein binding (GO:0042288),-0.46099498639506015,-1.174829093184955,0.2523809523809524,0.6652258968461681,1.0,7/13,44.88%,DERL1;ABCB9;TAP1;TAPBP;ATP5F1B;TAP2;LILRB1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5066488994235461,-1.1728564700757993,0.27699530516431925,0.6622962869891896,1.0,3/10,3.69%,SLC6A13;SLC6A1;SLC6A12
prerank,metalloexopeptidase activity (GO:0008235),0.44705877125370513,1.1727254982540387,0.27190721649484534,0.8803599836890753,1.0,7/51,7.40%,MMP17;AGBL1;LNPEP;RNPEP;CPA4;CPA3;ENPEP
prerank,GDP binding (GO:0019003),0.4423478329017381,1.1715954926923349,0.25985221674876846,0.8776155519962621,1.0,8/63,9.85%,RASL12;RAP1A;RERG;GEM;RAP2C;RRAS;MIEF1;RAP2A
prerank,microtubule motor activity (GO:0003777),0.4468435231646475,1.170571577699325,0.2669270833333333,0.8744654650684901,1.0,18/51,17.27%,KIF27;KIF2A;DYNLRB1;KIF3B;DNAH17;KIF1A;KIF5B;CENPE;KIF1C;DYNC1I2;KIF5C;KIF5A;APPBP2;KIF20B;KIF18A;KIF6;KIF7;STARD9
prerank,MAP kinase activity (GO:0004707),-0.46284977640398695,-1.1675435008236605,0.2645631067961165,0.6680507456461141,1.0,7/14,26.73%,MAPK14;MAPK4;MAPK9;MAPK6;MAPK7;MAPK10;MAPK8
prerank,store-operated calcium channel activity (GO:0015279),0.5852347064356633,1.1669507073243865,0.3172541743970315,0.8794158688563888,1.0,2/10,8.89%,TRPC6;TRPC5
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.399929827830133,-1.1659811894754144,0.2409972299168975,0.6652116135818253,1.0,13/22,32.97%,OTUD7B;PARP10;OPTN;IKBKG;TAB2;ATRIP;WDR81;PRPF8;ZBTB1;IKBKE;SQSTM1;TNFAIP3;MINDY2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5266573625046402,1.164370610786904,0.3218588640275387,0.8810066725663077,1.0,4/16,8.59%,ALOX5;ETHE1;HGD;ADI1
prerank,frizzled binding (GO:0005109),-0.3628283519427811,-1.1633144091147432,0.23214285714285715,0.6648529173433745,1.0,13/34,33.22%,WNT4;WNT5A;WNT9A;SDCBP;RNF43;WNT6;MYOC;ZNRF3;WNT16;DVL2;WNT11;CCDC88C;BAMBI
prerank,MAP kinase phosphatase activity (GO:0033549),0.5609036415015612,1.1608721427100719,0.3311036789297659,0.8857216941068036,1.0,4/12,12.81%,DUSP5;DUSP3;DUSP29;DUSP16
prerank,syntaxin-1 binding (GO:0017075),0.4917986065387746,1.1537287515921535,0.32436708860759494,0.9007412467657102,1.0,2/22,1.34%,STXBP2;SYPL2
prerank,monocarboxylic acid binding (GO:0033293),0.5289299697107871,1.1534982350548764,0.32733224222585927,0.8954254260234282,1.0,2/18,4.32%,NR1H4;NR2F2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5461598970510437,1.1518763089631194,0.32771535580524347,0.8944048309564485,1.0,3/12,8.49%,CRYZ;DHRS4;CBR1
prerank,N-acetyltransferase activity (GO:0008080),0.5198133592474345,1.1484736293167808,0.33164983164983164,0.899319167770433,1.0,8/19,18.44%,NAT10;SAT2;NAT8L;NAT8;NAT14;NAT2;NAT1;ESCO1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4452521227304363,1.1463916713576585,0.28418230563002683,0.899763694901162,1.0,7/44,9.03%,PRDM16;SMYD1;SUV39H2;ASH1L;KMT2D;SETD3;NSD3
prerank,voltage-gated ion channel activity (GO:0005244),0.547063129553103,1.1451904464509424,0.3248175182481752,0.8972419388901548,1.0,3/14,8.75%,CACNA1H;ANO6;VDAC1
prerank,protein phosphatase 1 binding (GO:0008157),0.49768823836467396,1.1451567296810428,0.3198051948051948,0.8916160960955785,1.0,2/21,5.81%,PPP1R3A;AKAP11
prerank,growth factor receptor binding (GO:0070851),0.4037625167914426,1.145133468395026,0.2834928229665072,0.8859994663845754,1.0,16/95,10.74%,FGF1;HIP1;PDGFB;PDGFC;IL2;PDGFD;ATXN2;VEGFA;IL12RB1;AREG;PIBF1;ITGB3;ADAM17;PDGFRB;HBEGF;PDGFA
prerank,leucine zipper domain binding (GO:0043522),0.5764190139231548,1.1439502004413815,0.33512544802867383,0.8839105876368375,1.0,5/10,18.00%,MRTFA;DAPK3;PAWR;PMF1;DDIT3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3530832297614188,-1.1421720643189812,0.27936507936507937,0.7144133739218151,1.0,9/32,12.77%,KDM7A;KDM2A;TET3;TET2;EGLN3;BBOX1;PHYH;EGLN2;RIOX2
prerank,cadherin binding (GO:0045296),0.37826827209514,1.1421177902040802,0.2345803842264914,0.8833835203422536,1.0,48/315,10.23%,CTNNA3;FLNA;NOTCH3;CDH6;PDLIM1;PDLIM5;CALD1;VASN;VCL;ESYT2;PFKP;CNN2;MYH9;PHLDB2;COBLL1;CDH13;ANXA1;PACSIN2;BZW2;ITGB1;TAGLN2;MYO1B;CDH4;ARHGEF16;CDHR3;MPP7;EPN2;NDRG1;DAB2IP;CHMP5;KTN1;PTPN1;TLN1;CNN3;KIF5B;CDH2;PPP1CA;ANLN;PKN2;PAK2;ARHGAP1;LRRFIP1;EPHA2;BAG3;PARVA;IST1;STK24;EIF3E
prerank,potassium ion antiporter activity (GO:0022821),-0.43966951814008626,-1.14206999099289,0.2760416666666667,0.7071340276852044,1.0,7/15,27.33%,SLC24A3;SLC9A2;SLC9A6;SLC9A9;SLC9A5;SLC24A2;SLC24A4
prerank,nucleoside-diphosphatase activity (GO:0017110),0.5691540115612658,1.13917703813642,0.3612662942271881,0.8864542074140479,1.0,2/12,7.16%,ENTPD1;ENTPD7
prerank,telomeric DNA binding (GO:0042162),-0.3617269172432615,-1.1350407834780545,0.28753993610223644,0.7183963557080504,1.0,12/32,17.92%,UPF2;XRCC5;STN1;SMG1;RAD50;BLM;XRCC6;HNRNPD;CTC1;TERF2IP;KDM1A;SMG6
prerank,wide pore channel activity (GO:0022829),0.48670468930007027,1.1333140978144016,0.32457496136012365,0.8989813802730172,1.0,4/23,11.42%,GJD3;GJC1;PANX1;GJA4
prerank,nuclear localization sequence binding (GO:0008139),0.5037684128678558,1.1327934939601678,0.33553719008264465,0.8949755285579793,1.0,7/18,14.38%,CABP1;KPNA4;NUP153;RANBP6;KPNA2;KPNA3;IPO4
prerank,solute:proton symporter activity (GO:0015295),-0.4131494864019716,-1.132387813101525,0.27154046997389036,0.7177260584003783,1.0,4/16,7.66%,SLC2A13;SLC25A3;SLC39A8;CTNS
prerank,exonuclease activity (GO:0004527),-0.3353055871510707,-1.131637976944684,0.2490118577075099,0.712545821513152,1.0,22/46,27.20%,REXO5;MRE11;ENPP2;RAD50;FAN1;ENPP3;TRIR;EXOSC1;REXO1;ENPP1;ISG20L2;EXOSC9;ZC3H12A;EXOSC2;RAD1;AEN;DCLRE1B;EXOSC7;EXOSC3;EXOG;EXD1;EXOSC5
prerank,ubiquitin protein ligase activity (GO:0061630),-0.24473077135088836,-1.1267114957781632,0.10344827586206896,0.718283326760265,1.0,58/228,15.38%,RNF220;KCMF1;RNF145;NEDD4L;SH3RF1;TRIP12;AREL1;ITCH;RNF38;CUL3;RNF185;MYCBP2;PPIL2;UBE2D3;RNF135;RC3H2;RNF144B;SHPRH;RNF217;TRIM24;RNF6;UBR2;BIRC2;RNF25;RNF13;HERC2;LTN1;MDM2;PELI1;TOPORS;TRIM25;WWP1;SH3RF3;SMURF2;RNF144A;PRKN;UBE3A;MGRN1;MKRN2;RNF181;UBE4B;TRIM5;RNF34;STUB1;DTX1;VPS18;TRIM14;RNF125;DTX3L;RNF166;SH3RF2;SIAH1;RNF115;HECW1;BIRC3;RNF10;NHLRC3;RNF43
prerank,thyroid hormone receptor binding (GO:0046966),-0.35939722084243986,-1.1258143940148526,0.2762237762237762,0.7133176478881926,1.0,6/28,6.47%,NSD1;MED13;TRIP12;TACC1;MED17;PRMT2
prerank,pyridoxal phosphate binding (GO:0030170),0.48611231730321314,1.121032438527861,0.3323076923076923,0.9241460736093197,1.0,3/20,10.83%,PYGM;PYGB;ACCS
prerank,cation transmembrane transporter activity (GO:0008324),-0.31502488719523236,-1.1201676657746342,0.23481781376518218,0.7215634335263172,1.0,18/48,22.84%,SLC41A1;SLC6A6;SLC3A2;SLC7A5;SLC6A9;SFXN2;SLC39A1;SLC66A1;SLC38A5;SLC38A6;SLC25A38;SLC8B1;SLC38A7;MMGT1;SLC15A4;SLC1A4;SLC36A1;SLC1A1
prerank,gap junction channel activity (GO:0005243),0.49031455996186646,1.1196093738332045,0.33751962323390894,0.9225048747584697,1.0,4/22,11.42%,GJD3;GJC1;PANX1;GJA4
prerank,U6 snRNA binding (GO:0017070),0.533529362451886,1.1177553729918654,0.3826247689463956,0.9222503590680335,1.0,3/14,10.93%,LSM8;EIF5A;PRPF4
prerank,galactosyltransferase activity (GO:0008378),-0.4746065024104328,-1.114803120294858,0.32805429864253394,0.7288634962314535,1.0,8/11,36.38%,B4GALT1;B4GALT6;B4GALT4;B4GALT7;B4GALT3;B4GALT2;A3GALT2;B3GALT6
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3282184932893412,-1.1136125070839071,0.25259515570934254,0.7246333540157279,1.0,11/37,12.30%,SLC22A8;SLCO2B1;SLCO1C1;SLCO2A1;CYB5A;SLC22A6;UQCRC1;SLCO3A1;SLC22A4;COX10;ATP13A3
prerank,protein tyrosine kinase activator activity (GO:0030296),0.4961686242970467,1.1061018247148215,0.34894991922455576,0.9510129441518006,1.0,5/19,13.57%,ANGPT4;CCL5;ERCC6;PAK2;GAS6
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.4208929970512716,-1.104202212054323,0.34134615384615385,0.7435027616359027,1.0,9/15,31.81%,SLC1A3;SLC17A6;SLC38A7;SLC1A4;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6
prerank,G protein-coupled receptor activity (GO:0004930),0.364907221216855,1.1010229652456818,0.30801248699271594,0.9606543424471252,1.0,18/239,10.07%,AGTR1;LHCGR;GPR20;HCRTR1;CRHR2;S1PR3;VIPR2;ADRA1D;TSHR;TAPT1;CYSLTR2;CXCR6;GPR17;NTSR2;XPR1;PTH1R;ADGRL2;PDGFRB
prerank,protein kinase binding (GO:0019901),0.3556400320670169,1.0977766798294395,0.25502008032128515,0.9647530662000382,1.0,62/479,10.14%,ACTA2;ARHGEF7;TTN;PPP1R12A;RYR2;INKA2;PDLIM5;PRKAB2;LIMS1;CCNA2;FERMT2;FZD5;CCND2;CSPG4;FAM83D;DUSP5;KCNA5;ITGB1;RHOBTB3;LAX1;HDAC9;PARN;ANKRD2;TSKS;ACTB;UTRN;DOK7;IRS1;LYST;CAV1;MAPT;DAB2IP;MAPKAPK2;DUSP3;TP53;PARP1;PIN1;PTPN1;CALM1;TPX2;PLEK;RAD9A;SOX9;ADD2;RELA;PKIA;TNIP1;TRIM68;CCND1;RHOF;PRKAR1B;VDAC1;GSTP1;PPP1CB;SKI;PAK2;TOM1L2;ADCY6;HIF1A;CEP192;PDGFRB;GYS1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.306602837322878,-1.0974870486841073,0.291866028708134,0.7542206319865135,1.0,14/55,9.67%,SLC6A13;SLC16A12;SLC13A3;PDPN;SLC16A9;SLC6A12;SLC6A6;SLC16A1;SLC7A14;SLC25A32;SLC7A5;SLC16A11;SLC38A10;SLC22A4
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4469379024264609,1.0970624947360448,0.36082474226804123,0.9612491947774834,1.0,6/31,11.35%,TMEM38B;KCNQ4;ABCC8;TMEM38A;KCNK3;KCNA2
prerank,carboxylic acid binding (GO:0031406),-0.3331116637096711,-1.0970451662467204,0.3143939393939394,0.7481269153090868,1.0,14/38,25.67%,GRM7;UBR2;GLRB;NOS3;GRIN3A;GLRA2;PHYH;SRR;HIF1AN;EPDR1;GLRA1;PSAP;SESN2;GCLC
prerank,ferrous iron binding (GO:0008198),-0.3842429525208213,-1.0969057336174288,0.32222222222222224,0.7413339744513793,1.0,11/21,26.20%,TET2;EGLN3;FTL;FTH1;PHYH;EGLN2;SNCA;CDO1;HIF1AN;ISCU;FECH
prerank,peptide hormone receptor binding (GO:0051428),-0.46216410284978626,-1.093964241686528,0.35990338164251207,0.7422091408607493,1.0,5/11,37.68%,PSMC5;PTHLH;ADCYAP1;GNRH1;CCK
prerank,TBP-class protein binding (GO:0017025),-0.379334351463636,-1.0929667153873353,0.3160919540229885,0.7378208523730682,1.0,11/21,26.88%,YEATS2;AHR;ESR1;DR1;PSMC5;PSMC2;TAF12;TAF13;GTF2A2;DRAP1;HHEX
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.45396307745964887,-1.092228219871147,0.3403755868544601,0.7328262282761799,1.0,2/11,5.36%,SASH1;STK38
prerank,inward rectifier potassium channel activity (GO:0005242),0.45947139319497055,1.0906711562946414,0.35736196319018404,0.9745131166996213,1.0,3/24,9.36%,KCNJ12;KCNN2;ABCC8
prerank,ATP binding (GO:0005524),0.3609516473311939,1.0899557586128614,0.3117948717948718,0.971044756392077,1.0,44/266,13.65%,RYR1;MAP3K20;STK38L;MAP3K5;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;MYO9B;RHOBTB3;MYO1B;KSR1;PEAK1;MARK1;BMPR1A;MYO18A;MAP4K3;MAP4K5;ABCE1;STK26;ERCC6;WNK2;DAPK3;PAPOLA;PRKACB;ABCD4;LONP1;BRSK1;HNRNPU;PFKM;DDX25;ABCG1;ACVR1B;DMPK;BMPR1B;CDC42BPB;SMARCA5;STK36;MAST1;ATP7B;PDK2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.36990154456349583,1.0892099050755484,0.3284518828451883,0.9674571058083956,1.0,20/188,8.05%,SOX6;PRDM16;SOX5;MEF2C;GABPA;ARID5B;HINFP;MTERF3;TBX18;KLF15;SUV39H2;JUND;ARID5A;TP53;GRHL1;SFPQ;AR;YAP1;RELA;KMT2D
prerank,poly-purine tract binding (GO:0070717),0.45451687779055905,1.0871222417367972,0.37037037037037035,0.9678500268328135,1.0,7/27,11.06%,RBPMS;RBMS3;MCRS1;ATXN1;PPIE;HNRNPU;DDX1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.4391757164155996,-1.084034833851947,0.38063063063063063,0.7471402100952422,1.0,4/11,11.08%,AKAP13;SH3RF1;MAPK8IP3;MAP2K2
prerank,translation elongation factor activity (GO:0003746),0.5046148816316934,1.084006774855647,0.39166666666666666,0.9714786660604936,1.0,7/14,18.09%,EEFSEC;GFM2;EIF5AL1;EIF5A;TSFM;GTPBP2;EEF2
prerank,ligand-gated cation channel activity (GO:0099094),0.3870549662852383,1.0817195533448762,0.3633004926108374,0.9724268271132966,1.0,9/75,12.48%,ASIC3;KCNJ12;GRIN2C;KCNN2;CCDC51;TRPM4;GRIK5;CHRNA7;TRPM2
prerank,copper ion binding (GO:0005507),0.42714354117077796,1.0802950205491757,0.35907859078590787,0.9710633269062211,1.0,11/42,18.02%,AOC3;LOXL2;RNF7;TP53;SUMF1;ATP7B;SNCG;MT3;SOD3;SNCB;P2RX4
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.44362533756655276,-1.079881364157633,0.3858093126385809,0.751079098767258,1.0,9/11,50.53%,HMCES;HMGA2;NEIL1;NEIL3;NTHL1;NEIL2;APEX1;APEX2;APLF
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4394041307502656,1.0775452663374663,0.37209302325581395,0.9734545166681386,1.0,5/29,8.72%,INKA2;PKIB;HEXIM1;PKIA;PRKAR1B
prerank,retinoid X receptor binding (GO:0046965),-0.44511716186100747,-1.0775024237714708,0.36018957345971564,0.7499620767227239,1.0,3/11,8.25%,NSD1;TACC1;MED25
prerank,nuclear import signal receptor activity (GO:0061608),0.4972123811142851,1.0760934657879515,0.38917089678510997,0.9722437856334024,1.0,8/15,20.74%,KPNA4;RANBP6;KPNA2;TNPO3;KPNA3;IPO4;IPO9;HIKESHI
prerank,sterol binding (GO:0032934),-0.29928384481355186,-1.0736605303050406,0.3167420814479638,0.7529044860575856,1.0,19/56,23.59%,OSBPL8;ABCA1;PTCH1;OSBPL10;GRAMD1C;ANXA6;APOD;SCARB2;SIDT1;PROM1;SOAT1;GRAMD1A;INSIG1;STARD4;OSBP;SYP;STARD3NL;STARD5;NPC1
prerank,magnesium ion binding (GO:0000287),0.3650624325285073,1.0735818100752783,0.35501653803748623,0.9742017852949387,1.0,18/135,9.85%,MAP3K20;STK38L;MAP3K5;UBA2;DYRK2;ADCY2;GEM;MARK1;TESC;TPPP;STK26;OPA1;PAPOLA;PRKACB;DIS3L2;BRSK1;AASDHPPT;RAP2A
prerank,amino acid binding (GO:0016597),-0.33995706276253823,-1.0730026428615935,0.3258785942492013,0.7481607942097734,1.0,11/31,21.40%,GRM7;GLRB;NOS3;DDAH1;GRIN3A;GLRA2;SRR;AARS1;DDAH2;GLRA1;ASS1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3507598580249327,1.0713567508169073,0.3329979879275654,0.9750431118907408,1.0,71/431,14.41%,RYR1;RASL12;MAP3K20;RAP1A;STK38L;MAP3K5;TUBA1C;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;RRAD;MYO9B;RERG;GEM;RHOBTB3;MYO1B;MFHAS1;KSR1;PEAK1;MARK1;SEPHS1;BMPR1A;MYO18A;MAP4K3;MAP4K5;RAP2C;RRAS;RANBP17;TUBB2B;RHOJ;ABCE1;STK26;ERCC6;WNK2;DAPK3;PAPOLA;PRKACB;RHOF;ABCD4;LONP1;BRSK1;RRAGB;RAP2A;HNRNPU;REM1;PFKM;DDX25;RHOH;ABCG1;ACVR1B;DRG2;DMPK;BMPR1B;GBP2;CDC42BPB;SMARCA5;STK36;ADSS1;MAST1;LSG1;ATP7B;PDK2;TUBD1;SARS2;RAB14;LRRK2;DIRAS2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.301273701816471,-1.0701383127825486,0.3275862068965517,0.749033260882975,1.0,20/49,24.55%,UBQLN1;OTUD7B;UBL7;UFD1;PARP10;OPTN;IKBKG;TAB2;BRCC3;EPS15;DZIP3;MINDY1;UBXN1;ATRIP;UBQLN2;WDR81;SHARPIN;PRPF8;ZBTB1;RAD23B
prerank,protein tyrosine kinase binding (GO:1990782),0.38842286834590267,1.0645819588805714,0.37772397094430993,0.9893803586622824,1.0,10/71,6.82%,ANGPT2;ANGPT1;ANGPT4;SOCS5;ITGB1;PITPNM3;ARHGEF16;DUSP3;TP53;PTPN1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.4390546973369004,-1.0640697487077573,0.36674816625916873,0.7586933130838551,1.0,6/12,25.69%,SLC9B2;SLC9A2;LETM1;SLC9A6;SLC9A9;SLC9A5
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.3695445384255015,-1.063896068790053,0.37735849056603776,0.7527064472632453,1.0,4/20,7.73%,SENP1;SENP3;COPS2;USP7
prerank,low-density lipoprotein particle binding (GO:0030169),0.4987669343950115,1.0633239350018882,0.40033500837520936,0.9876992832483547,1.0,2/16,2.68%,CD36;CDH13
prerank,nucleotidyltransferase activity (GO:0016779),0.4691151185599477,1.0632464259113614,0.3924466338259442,0.9825324155547182,1.0,4/19,8.44%,CGAS;CRPPA;TERT;TENT4A
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.5018733198010985,1.06016563502457,0.41975308641975306,0.9858041165856545,1.0,3/13,5.56%,WDR4;FTSJ1;TRMT10C
prerank,estrogen receptor binding (GO:0030331),-0.3285470519747806,-1.0570362250199532,0.35906040268456374,0.7639076144905315,1.0,8/32,10.50%,NSD1;LEF1;TACC1;NCOA1;PRMT2;CTNNB1;ESR1;TRIP4
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4961480307952849,1.056930523270604,0.4190800681431005,0.9893690556330254,1.0,2/14,4.10%,KCNA5;KCNE4
prerank,iron ion binding (GO:0005506),-0.30272106612941146,-1.0565316008944396,0.36213991769547327,0.7587727083325466,1.0,13/48,15.10%,AGMO;KDM7A;FBXL5;AOX1;TET2;JMJD6;EGLN3;FTL;FTH1;PHYH;EGLN2;SNCA;CDO1
prerank,platelet-derived growth factor binding (GO:0048407),0.5171436676799864,1.054441433722461,0.4186046511627907,0.9909715171175961,1.0,5/11,12.43%,COL4A1;PDGFB;PDGFRB;PDGFA;COL3A1
prerank,deubiquitinase activity (GO:0101005),-0.26448244218805567,-1.0518898649496629,0.30344827586206896,0.7647368281915035,1.0,24/88,19.25%,ATXN3;USP53;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;USP29;MINDY1;PAN2;VCPIP1;USP37;OTUD3;EIF3F;USP24;ZC3H12A;USP10;USP32
prerank,adenyl ribonucleotide binding (GO:0032559),0.34690849345504976,1.0516780042702276,0.3943089430894309,0.9934587115341583,1.0,46/291,13.01%,RYR1;MAP3K20;STK38L;MAP3K5;ACTA1;UBA2;DYRK2;PFKP;CDK6;MYH9;PDK4;MYO9B;RHOBTB3;MYO1B;KSR1;PEAK1;MARK1;BMPR1A;PDE4A;MYO18A;MAP4K3;MAP4K5;COQ8A;ABCE1;STK26;ERCC6;MIEF1;WNK2;DAPK3;PAPOLA;PRKACB;ABCD4;LONP1;BRSK1;HNRNPU;PDE4D;PFKM;DDX25;ABCG1;ACVR1B;DMPK;BMPR1B;CDC42BPB;SMARCA5;STK36;MAST1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.49090440119707124,1.0506350389659407,0.4355108877721943,0.9910011840556345,1.0,3/15,9.35%,NDST3;HS2ST1;HS6ST1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.45486279241008215,1.048424090560183,0.4124031007751938,0.9917965690230031,1.0,5/22,13.20%,RBM24;RBMS3;CPEB1;CPEB3;ZFP36L1
prerank,chloride channel regulator activity (GO:0017081),-0.4053519149428531,-1.0482262532910858,0.39902676399026765,0.7678352388840569,1.0,6/14,17.84%,WNK1;WNK4;WNK3;STX1A;VAMP8;STX8
prerank,anion channel activity (GO:0005253),0.38852972190756857,1.0469278916246019,0.4193138500635324,0.9908650856860407,1.0,10/61,11.98%,ANO1;GABRE;ANO6;GABRA4;GABRA5;VDAC1;GABRB2;GABRG1;ANO3;GABRB3
prerank,5'-nucleotidase activity (GO:0008253),0.4826347000328391,1.0460518657190896,0.40407470288624786,0.9883057284372517,1.0,5/13,19.79%,ACP3;NT5C2;NT5M;NT5C3A;NT5C
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.26130934311012965,-1.0446590970267342,0.30864197530864196,0.7713431048831603,1.0,22/83,19.25%,ATXN3;USP53;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;USP29;PAN2;VCPIP1;USP37;OTUD3;USP24;ZC3H12A;USP10;USP32
prerank,serine-type peptidase activity (GO:0008236),0.36469987065731163,1.0429032983923674,0.4011363636363636,0.9921157902657398,1.0,7/96,10.51%,TMPRSS4;HTRA1;KLK2;APEH;PRSS8;MASP2;MBTPS1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3013297453609838,-1.0404021912993473,0.4080717488789238,0.7762733534491608,1.0,17/47,18.62%,SLC7A11;SLC6A13;SLC47A1;PDPN;SLC6A1;SLC6A6;SLC7A14;SLC3A2;SLC7A5;SLC38A10;SLC22A4;SLC43A2;SLC66A1;SLC38A5;SLC38A6;SLC38A7;SLC7A7
prerank,nuclear receptor binding (GO:0016922),0.35998665459819823,1.0399507296732566,0.40245261984392416,0.995464693830796,1.0,24/111,11.69%,ACTN4;SMARCD3;NR1H4;NR4A1;RERG;PADI2;ARID1A;TGFB1I1;NCOA7;ASXL1;TAF1;ARID5A;HMGN3;PPARGC1A;MED1;PPARGC1B;MED12;TRIM68;NR4A2;HIF1A;MED14;TACC2;BAZ2A;ZBTB7A
prerank,cyclic nucleotide binding (GO:0030551),0.45832821387907957,1.0387900211248788,0.4333868378812199,0.9932851104488732,1.0,4/21,11.18%,PDE5A;PDE4A;KCNH1;PDE4D
prerank,semaphorin receptor binding (GO:0030215),-0.3542797019507997,-1.0369079890055772,0.42480211081794195,0.7791031381976405,1.0,7/23,11.11%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4960144889234872,1.03676612127638,0.4500875656742557,0.9939135731700134,1.0,2/13,2.62%,PIP5K1B;PIP4K2A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5146792806443263,1.0343557070131266,0.4573502722323049,0.9949708552193692,1.0,1/10,3.53%,DCTD
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5105635455012661,1.0327782773313396,0.4478114478114478,0.9942554481414669,1.0,6/12,19.82%,CDK6;CDK7;CDK12;MAPK1;BRD4;CDK13
prerank,PDZ domain binding (GO:0030165),0.38463516532315706,1.0300889625890537,0.4149746192893401,0.9962659906683887,1.0,14/61,14.24%,ATP2B4;SDC2;CRIM1;FZD4;ARHGEF16;FZD8;SYNJ2;ATP2B1;ADAM17;SLC22A5;TMEM88;NSF;TMEM88B;PLEKHA1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3450971769963363,1.029941587638566,0.42901234567901236,0.9916735180737343,1.0,56/248,16.94%,RASL12;RAP1A;MYO1E;MYL6;MYH9;KIF2A;RERG;GEM;RHOBTB3;GNAO1;GNAZ;MYO18A;NKIRAS2;KIF1A;RAP2C;TPPP;RRAS;ABCA3;PIN1;RHOJ;RAB3A;ENTPD7;OPA1;ATP2B1;RHOF;GNA12;GNG11;RRAGB;RAP2A;GFM2;ATAD1;KIF1C;DNM1L;GSPT1;MFN2;RHOH;RUVBL1;DRG2;KIF5A;GBP2;CLU;KIF20B;LSG1;GNAQ;RAB14;LRRK2;DIRAS2;RAB8B;RHOG;DNM2;VWA8;RHOT1;AGAP2;RAB8A;DHX9;RAB38
prerank,retinoic acid receptor binding (GO:0042974),0.47090124688458146,1.0289284513676649,0.4532710280373832,0.9896224016136609,1.0,5/17,9.09%,ACTN4;ASXL1;ARID5A;MED1;NR4A2
prerank,endoribonuclease activity (GO:0004521),-0.3167834310343962,-1.027292181025464,0.4070175438596491,0.7969775380900768,1.0,12/32,25.88%,AGO3;ZC3H12B;TSNAX;ERN1;ZC3H12C;SMG6;ZC3H12A;RNASEL;INTS11;KHNYN;EXOG;SND1
prerank,lipase activator activity (GO:0060229),0.5175152126546575,1.0269989925270286,0.4511545293072824,0.989713721978379,1.0,2/10,4.86%,CCL5;ARHGAP6
prerank,GTP binding (GO:0005525),0.34497008395682005,1.0231591475900668,0.4351063829787234,0.994881500614558,1.0,34/172,16.94%,RASL12;RAP1A;TUBA1C;RRAD;RERG;GEM;RHOBTB3;MFHAS1;SEPHS1;RAP2C;RRAS;RANBP17;TUBB2B;RHOJ;RHOF;RRAGB;RAP2A;REM1;RHOH;DRG2;GBP2;ADSS1;LSG1;TUBD1;RAB14;LRRK2;DIRAS2;RHOG;DNM2;RHOT1;AGAP2;RAB8A;ARL4D;RAB38
prerank,fibroblast growth factor receptor binding (GO:0005104),0.44029309319964016,1.0203787752118385,0.44680851063829785,0.9972644927563155,1.0,1/21,1.46%,FGF1
prerank,omega peptidase activity (GO:0008242),-0.25245713138961995,-1.0198440010200591,0.3783783783783784,0.8091958055211815,1.0,29/89,24.98%,ATXN3;USP53;USP46;USP11;MINDY3;OTUD7B;USP45;UFD1;USP19;USP7;USP12;BRCC3;USP3;ASRGL1;USP29;PAN2;VCPIP1;USP37;OTUD3;USP24;ZC3H12A;USP10;USP32;MPND;USP25;CYLD;GGT7;OTUD1;UCHL1
prerank,poly(A) binding (GO:0008143),0.44058445440991706,1.0178679636799701,0.4565560821484992,0.9993741849573002,1.0,5/21,11.06%,RBPMS;RBMS3;PPIE;HNRNPU;DDX1
prerank,endonuclease activity (GO:0004519),-0.28364857062432564,-1.0169705523865233,0.40625,0.8102503128103514,1.0,18/49,27.55%,AGO3;ZC3H12B;MRE11;N4BP2;TSNAX;ERCC5;DIS3;ERN1;ZC3H12C;SMG6;ZC3H12A;RNASEL;INTS11;KHNYN;ERCC4;EXOG;SND1;OGG1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.3313712917661108,-1.015649071593382,0.42765273311897106,0.8071290568465205,1.0,6/25,9.33%,POR;CYP27A1;CYP26B1;FMO1;FMO2;NOS3
prerank,tRNA binding (GO:0000049),0.39682518067676653,1.0147581376200514,0.43843031123139375,1.0,1.0,15/43,17.63%,HSD17B10;NAT10;TYW5;TRMT10C;TERT;PSTK;SEPSECS;AIMP1;NSUN2;RPUSD4;SARS2;KARS1;SARS1;FARS2;EIF2AK4
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.42602480053885095,-1.0145801373871086,0.46382978723404256,0.8035886757397971,1.0,3/11,7.55%,CARM1;PRMT2;PRMT3
prerank,semaphorin receptor activity (GO:0017154),-0.4324944687318223,-1.0141997463596184,0.4589041095890411,0.7983350652396571,1.0,4/11,8.24%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,sulfotransferase activity (GO:0008146),-0.3158422547161861,-1.012625474196641,0.4326241134751773,0.796693881095608,1.0,5/33,8.17%,UST;CHST11;HS3ST3A1;CHST9;TPST1
prerank,ribonuclease activity (GO:0004540),-0.27712209108031344,-1.0125012299331286,0.4329896907216495,0.7908710121811875,1.0,22/56,27.90%,AGO3;ZC3H12B;TSNAX;SAMHD1;EXOSC1;RNASE4;ERN1;ZC3H12C;EXOSC9;SMG6;ZC3H12A;EXOSC2;RNASEL;INTS11;PPP1R8;KHNYN;EXOSC7;EXOSC3;EXOG;SND1;EXOSC5;ELAC2
prerank,ATPase regulator activity (GO:0060590),0.39542164250730677,1.011105718738844,0.4262734584450402,1.0,1.0,11/38,19.22%,PLN;ATP1B1;BAG3;DNAJC1;FNIP2;BAG2;HSPBP1;DNAJA2;DNAJB6;BRSK2;SIL1
prerank,metalloendopeptidase activity (GO:0004222),0.3691495480460253,1.0069452486434685,0.44781553398058255,1.0,1.0,15/76,15.09%,MMP17;ADAMTS14;ADAMTS5;ADAMTS19;AFG3L2;TRABD2B;ADAM17;MIPEP;THSD4;PHEX;ADAMTS20;ADAMTS16;PMPCB;ADAM19;ADAMTSL4
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4076436759082567,-1.0057630944316325,0.45255474452554745,0.8020621252022381,1.0,6/13,25.69%,SLC9B2;SLC9A2;LETM1;SLC9A6;SLC9A9;SLC9A5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4998288293527374,1.004984906792068,0.4706959706959707,1.0,1.0,2/10,11.27%,DPYSL4;OPLAH
prerank,cytokine receptor binding (GO:0005126),0.36245745080586317,1.0035488639657186,0.44770857814336074,1.0,1.0,12/83,10.34%,LIFR;CRLF1;IL2;CCL5;PXDN;VEGFA;IL12RB1;PIBF1;IL22;TGFB2;ADAM17;IL13RA1
prerank,double-stranded DNA binding (GO:0003690),-0.21778034350514638,-1.0032657564278022,0.5,0.8021835991480986,1.0,120/531,20.10%,TCF4;FLI1;NFAT5;ZBTB20;HLF;RBMS1;LEF1;NFATC3;HOXB6;FOXP1;ZIC1;ELF1;HMGB1;KDM5B;PKNOX2;CREM;ZIC4;KLF12;E2F3;GLI2;EGFR;ERG;CREB5;PKNOX1;RUNX2;JDP2;PRKDC;XRCC5;CUX1;HOXB4;MTF1;ARNT2;ELK3;PRRX2;TBX15;HOXA5;MRE11;WDR48;MEOX2;ELK4;MBD1;POLR3F;CRY1;KLF3;ZFP1;GLIS1;FOXC2;POU6F1;RAD50;FBH1;TFEB;MAU2;HSF2;TFCP2;CAMTA1;ERCC5;MAX;NR3C1;RFX2;AHR;MEIS2;OSR1;ESR1;MAFG;ATF2;ZNF740;SIX1;ZNF177;DDX60;HES1;TEAD2;ZIC5;IRF9;CREB1;TARDBP;XRCC6;SOX4;BHLHE41;ZNF76;KLF2;GMEB2;CEBPB;ELF2;ELK1;MAF;KLF10;ARNT;TEF;BHLHE40;CREB3L1;ATF7;GLIS2;KLF5;VSX1;KLF13;RARA;NFIB;TFE3;SMAD2;LHX6;PPARG;NPAS2;XPA;RORB;TFCP2L1;KLF11;E2F4;HOXB8;TGIF1;HSF1;CAMTA2;PARK7;MECP2;THRB;SATB1;HOXB9;HOXA9;MSH6;ONECUT2;NFATC2
prerank,insulin-like growth factor I binding (GO:0031994),-0.39533424033920483,-1.0002468983691146,0.4470046082949309,0.8035279523052806,1.0,6/13,14.29%,IGFBP2;ITGA6;IGFBP3;ITGAV;IGFBP6;INSR
prerank,SUMO binding (GO:0032183),0.47080991820764284,1.000118234773618,0.4807692307692308,1.0,1.0,3/13,11.10%,UBA2;CBX4;CASP8AP2
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.41958421403370116,-0.9989099832371399,0.46938775510204084,0.8008996841658386,1.0,4/11,16.78%,STN1;RAD50;CTC1;TERF2IP
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.33595093474007987,0.9985440571638844,0.46680716543730244,1.0,1.0,24/173,11.71%,PRDM16;HEY2;ZFHX3;TBX2;ZEB2;ETS2;HEYL;ZNF436;NACC2;PRDM1;OSR2;TBX18;KCNIP3;SNAI2;RELA;PPARA;SKI;NR1D1;LRRFIP1;ZBTB33;ZNF3;SREBF2;ATF3;NFX1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.41842260429676686,0.9976405690609548,0.4618705035971223,1.0,1.0,7/28,15.38%,MYD88;DAB2IP;TRAF3;TRAF5;CASP8AP2;FEM1B;STAT1
prerank,small GTPase binding (GO:0031267),0.3365040458113866,0.9949328550452665,0.48352816153028694,1.0,1.0,40/169,14.68%,FLNA;RNF152;PLCE1;MYO9B;RHOBTB3;STRN3;UNC13D;TBC1D20;TNFAIP1;BICD2;ARHGEF16;KIF3B;ARHGEF2;MTSS2;RUSC2;CAV1;NDRG1;RABGAP1;CYFIP1;RAPGEF6;PEX5L;EVI5;DAPK3;WHAMM;DENND10;PAK2;ARHGAP1;ANKFY1;RAB11FIP3;RAB11FIP4;DNM1L;SH3BP4;RHOH;XPO5;HPS4;MYO5B;TNPO3;LRRK2;ANKRD27;RAB34
prerank,snRNA binding (GO:0017069),0.39062732041366977,0.9942659064609337,0.4489795918367347,1.0,1.0,10/42,15.95%,LSM8;HEXIM1;SF3B3;CCNT1;HNRNPU;EIF5A;PRPF4;SNRPB2;RBM41;LSM10
prerank,metallopeptidase activity (GO:0008237),0.349208267209417,0.9918556840147023,0.4842696629213483,1.0,1.0,17/113,11.90%,MMP17;PAPPA2;ADAMTS14;ADAMTS5;ADAMTS19;LNPEP;RNPEP;AFG3L2;TRABD2B;ADAM17;MIPEP;THSD4;ADAM18;PHEX;ADAMTS20;ADAMTS16;EIF3H
prerank,nuclear receptor coactivator activity (GO:0030374),0.38267509006851325,0.9914626872564927,0.4649122807017544,1.0,1.0,9/52,10.58%,ACTN1;ACTN4;NCOA7;PPARGC1A;MED1;PPARGC1B;MED12;SFR1;MED14
prerank,DNA secondary structure binding (GO:0000217),0.4017170418508856,0.990783220035714,0.4809052333804809,1.0,1.0,3/31,6.17%,MEF2C;RAD51AP1;MAPT
prerank,cardiolipin binding (GO:1901612),-0.4192451755469234,-0.9903574578029517,0.48464912280701755,0.8164800988904731,1.0,5/10,25.65%,GSDME;GSDMD;STOML2;PLEKHN1;MME
prerank,double-stranded RNA binding (GO:0003725),0.36807226487901534,0.9894918504704374,0.4758961681087763,1.0,1.0,21/70,19.70%,ACTN1;VIM;MTDH;DICER1;EIF4A1;LRRFIP1;MBNL1;HNRNPU;EIF2AK2;DROSHA;OASL;DHX30;DGCR8;STAU2;RFTN1;DHX9;CLTC;PRKRA;ILF3;AGO1;ADARB1
prerank,serine-type endopeptidase activity (GO:0004252),0.3529254446532109,0.9864458614928535,0.4682352941176471,1.0,1.0,5/80,10.51%,TMPRSS4;KLK2;APEH;MASP2;MBTPS1
prerank,telomerase RNA binding (GO:0070034),0.4391737632134557,0.9851973641595837,0.48923076923076925,1.0,1.0,8/22,18.89%,PARN;TERT;NAF1;HNRNPU;HNRNPC;TEP1;SNRPD3;EXOSC10
prerank,CARD domain binding (GO:0050700),-0.3825907589910804,-0.9834891108715824,0.5059952038369304,0.8273137468329309,1.0,5/14,18.82%,NOD1;CARD10;IRGM;CARD14;CASP4
prerank,peptidoglycan binding (GO:0042834),-0.41783833572236717,-0.9831498860399397,0.482837528604119,0.8222071720052779,1.0,8/10,52.55%,NOD1;PGLYRP1;NOD2;RNASE7;JCHAIN;NLRP3;TLR2;HK1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3570924765381839,0.9827975565246345,0.4780426599749059,1.0,1.0,10/60,10.07%,NTRK3;MERTK;CRIM1;MST1R;ROR1;MUSK;IGF2R;EPHA2;AXL;PDGFRB
prerank,exoribonuclease activity (GO:0004532),-0.4069487169842485,-0.9826523576581725,0.4827586206896552,0.8176563225813762,1.0,7/12,27.20%,EXOSC1;EXOSC9;ZC3H12A;EXOSC2;EXOSC7;EXOSC3;EXOSC5
prerank,microtubule minus-end binding (GO:0051011),0.4764052020993528,0.9791425529714476,0.4879310344827586,1.0,1.0,5/13,19.60%,CEP290;TUBGCP6;HAUS7;HAUS4;CAMSAP1
prerank,AMP binding (GO:0016208),-0.3942638993518312,-0.9773606772686056,0.48237885462555063,0.8246006876772136,1.0,2/11,0.66%,MPPED2;PRKAG2
prerank,guanyl ribonucleotide binding (GO:0032561),0.32526355207363034,0.9772875104820251,0.5146443514644351,1.0,1.0,37/196,16.94%,RASL12;RAP1A;TUBA1C;PDE5A;RRAD;RERG;GEM;RHOBTB3;MFHAS1;SEPHS1;RAP2C;RRAS;RANBP17;TUBB2B;RHOJ;MIEF1;RHOF;RRAGB;RAP2A;REM1;RHOH;DRG2;GBP2;ADSS1;LSG1;TUBD1;RAB14;LRRK2;DIRAS2;RAB8B;RHOG;DNM2;RHOT1;AGAP2;RAB8A;ARL4D;RAB38
prerank,protein phosphatase 2A binding (GO:0051721),0.4270617669827152,0.9754652303728539,0.49133858267716535,1.0,1.0,6/23,7.70%,STRN3;MFHAS1;MAPT;DAB2IP;TP53;ENSA
prerank,hexosaminidase activity (GO:0015929),-0.39637848055684227,-0.9741296476410641,0.5127610208816705,0.8270316641701267,1.0,4/12,20.45%,CEMIP;HEXA;CEMIP2;NAGA
prerank,death domain binding (GO:0070513),-0.40386035065896797,-0.971268275955491,0.5277777777777778,0.8280470597862936,1.0,6/11,17.39%,DAP;BCL2L1;IRGM;DAPL1;BAX;CRADD
prerank,Notch binding (GO:0005112),-0.33509867708377206,-0.9705062300192945,0.48760330578512395,0.8241814097122475,1.0,9/22,19.81%,SNED1;AAK1;CUL3;CCN3;SNW1;DTX1;JAG2;NOTCH4;HIF1AN
prerank,lysophospholipase activity (GO:0004622),-0.3516617025869526,-0.9686953773497506,0.5118343195266272,0.8230439304893512,1.0,9/20,25.78%,LYPLA1;ENPP2;PLA2G6;GDPD1;ABHD12;ASPG;GDE1;PNPLA6;LYPLA2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.40476800516316935,0.9660983104976724,0.5107361963190185,1.0,1.0,7/27,14.44%,POLR2L;POLR2I;POLR2G;TERT;POLR1H;POLR2J;POLR3K
prerank,hormone receptor binding (GO:0051427),-0.3778881406382773,-0.962500568839411,0.5230024213075061,0.8321920524261318,1.0,6/14,37.68%,SOCS2;PTHLH;ADCYAP1;NCOA6;NPPC;CCK
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4156220633780267,-0.9620490744190864,0.5146726862302483,0.8276626606617656,1.0,4/10,12.81%,DSE;RENBP;DSEL;GLCE
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3656601111979041,-0.9607214959363767,0.5050761421319797,0.8251687328537198,1.0,8/15,30.15%,AGPAT4;ABHD5;LPCAT2;AGPAT5;AGPAT1;ABHD8;LCLAT1;AGPAT2
prerank,kinase activator activity (GO:0019209),0.39308320007069114,0.9597869913309443,0.5074404761904762,1.0,1.0,3/30,7.13%,FGF13;IL2;TPX2
prerank,cytokine activity (GO:0005125),-0.22497463155205455,-0.9597751321227661,0.6,0.8219755203676884,1.0,10/131,6.82%,BMP6;WNT4;BMP7;HMGB1;IL15;BMP4;IL18;WNT5A;CXCL16;WNT9A
prerank,hydro-lyase activity (GO:0016836),0.37276643348297966,0.9566512215210669,0.5006858710562414,1.0,1.0,8/41,9.77%,CA3;ENO3;TBXAS1;HSD17B4;HACD1;CDYL;ACO2;HADHB
prerank,phosphatidylcholine transporter activity (GO:0008525),0.445904865619507,0.954459539603663,0.5299837925445705,1.0,1.0,8/17,15.17%,ATP8B1;ABCB4;PITPNB;ABCA3;ATP10A;ABCG1;MTTP;PITPNM2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3495684493985938,0.9528580300977685,0.5328554360812425,1.0,1.0,7/70,6.60%,LARGE1;CHSY3;CSGALNACT1;EXT2;GCNT2;HAS2;RFNG
prerank,ephrin receptor binding (GO:0046875),-0.3322212789654281,-0.9516115335945856,0.5264705882352941,0.8361205840625303,1.0,5/21,13.87%,EFNB2;GRB2;ANKS1A;LYN;EFNB1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3604518591488742,0.9505111557535562,0.5057618437900128,1.0,1.0,5/49,4.63%,ESYT2;FER1L5;DYSF;ANXA1;SYT10
prerank,tau protein binding (GO:0048156),0.37889900270673943,0.9503872166366418,0.5161290322580645,1.0,1.0,15/40,19.39%,ROCK1;ACTB;MARK1;DYRK1A;PIN1;BRSK1;ROCK2;CLU;BAG2;MARK2;DCTN1;MAP1A;BRSK2;HDAC6;MARK3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.36408613759404573,0.9500093532114291,0.515032679738562,1.0,1.0,6/48,8.74%,ASIC3;TRPC6;PKD1L3;TRPV2;CALHM5;TRPM4
prerank,ion channel inhibitor activity (GO:0008200),0.38875532885012015,0.9483163317782095,0.5257142857142857,1.0,1.0,7/35,8.12%,ITPR1;PACSIN3;CAMK2D;CALM1;NEDD4;ENSA;WNK2
prerank,acetylcholine receptor activity (GO:0015464),0.40075042085989543,0.9472912808236477,0.503793626707132,1.0,1.0,5/22,15.30%,HRH3;ANXA9;CHRNA7;CHRFAM7A;CHRNA4
prerank,ATPase binding (GO:0051117),0.35132874628813554,0.9470916589637419,0.5209876543209877,1.0,1.0,8/71,7.14%,PLN;HRC;PPP3CA;SNTA1;ATP1B1;CAV1;ATP6V0A2;AR
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3216321630891214,0.9463267881579132,0.5480349344978166,1.0,1.0,27/147,12.75%,ARHGEF7;RAP1A;KALRN;ABR;PLCE1;ARHGEF17;RASGRP2;DOCK8;ITSN1;DOCK10;ARHGEF16;ARHGEF2;NUCB1;RCC1L;RAPGEF6;RASGRP1;DNMBP;RIN2;DENND10;ARHGEF4;DOCK1;VAV1;DENND1A;FRMD7;BCR;SBF1;HPS4
prerank,pyrophosphatase activity (GO:0016462),0.35856129942024123,0.9456770724216467,0.5488126649076517,1.0,1.0,8/50,8.91%,ENTPD1;NUDT7;NUDT4;PRUNE1;LHPP;BNIPL;ENTPD7;ATCAY
prerank,G protein-coupled receptor binding (GO:0001664),0.3207696682560372,0.9447695799018915,0.5808580858085809,1.0,1.0,6/132,5.21%,FLNA;AGTR1;CCL5;GNAO1;SAG;GNAZ
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.41431863060508306,0.943727985776893,0.5292397660818714,1.0,1.0,8/22,18.74%,DUSP5;DUSP3;DUSP29;SBF1;DUSP16;DUSP23;MTMR3;DUSP12
prerank,LRR domain binding (GO:0030275),0.4431832224646721,0.9428397685821528,0.5440677966101695,1.0,1.0,8/14,18.00%,MRTFA;DAPK3;ZXDC;PAWR;POLR2J;LRRFIP2;PMF1;DDIT3
prerank,glycerophospholipid flippase activity (GO:0140333),0.46396048731711004,0.9419115040025228,0.5311942959001783,1.0,1.0,4/11,11.16%,ATP8B1;ABCB4;ABCA3;ATP10A
prerank,transcription cis-regulatory region binding (GO:0000976),0.3074839754508593,0.9411200669127612,0.6287726358148893,1.0,1.0,49/406,11.80%,SOX6;PRDM16;SOX5;MEF2C;ACTN4;NR1H4;ALX4;RORA;SIM2;GABPA;ARID5B;HINFP;ZNF436;FOSL2;RBAK;VEZF1;MTERF3;OSR2;TBX18;MEF2A;GBX1;DBP;KLF15;SUV39H2;JUND;ARID5A;TP53;GRHL1;SFPQ;AR;YAP1;SOX9;SNAI2;RELA;KMT2D;CUX2;BBX;LONP1;NR1D1;HIF1A;ZNF3;NR2C2;TEAD1;RUNX1;RB1;ATF3;HOXC8;NFX1;PSPC1
prerank,phospholipid transfer activity (GO:0120014),-0.3312876883881562,-0.9411090743742346,0.5329512893982808,0.8554151288621937,1.0,10/21,24.00%,PITPNA;PLTP;PITPNC1;CERT1;PLEKHA3;TNFAIP8L3;PRELID3B;C2CD2L;PRELID2;PRELID3A
prerank,ubiquitin binding (GO:0043130),-0.2393801817576275,-0.9410841113073604,0.6203208556149733,0.8498216024106053,1.0,35/73,31.89%,SMAD3;UBXN7;RNF185;WDR48;ILRUN;BIRC2;UBAP1;MDM2;FBXO7;IKBKG;RBCK1;RNF31;PRKN;DNAJB2;BUB3;TOLLIP;UBXN1;MVB12B;RNFT1;UBAP1L;SHARPIN;USP25;MVB12A;RAD23B;UCHL1;TRIM32;RNF19B;SQSTM1;USPL1;MARK4;TNFAIP3;GGA3;VPS28;OTULINL;PLAA
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3478095658709044,0.9408660128724404,0.5319693094629157,1.0,1.0,11/60,12.19%,NTRK3;MERTK;MST1R;ROR1;ACVR2A;MUSK;EPHA2;AXL;PDGFRB;ACVR1B;BMPR1B
prerank,ATP hydrolysis activity (GO:0140603),0.36879878976283414,0.9387013745317443,0.5428194993412385,1.0,1.0,9/41,12.58%,MYO1E;RHOBTB3;MYO18A;ABCA3;ATP2B1;ATAD1;RUVBL1;CLU;KIF20B
prerank,hormone activity (GO:0005179),-0.26012694492549276,-0.9377612389436306,0.5782608695652174,0.852388695628585,1.0,21/54,40.74%,IGF1;CHGB;METRNL;PPY;PTHLH;EDN3;ADCYAP1;SST;PENK;VGF;INHBB;INHA;GNRH1;EDN1;NPPC;C1QTNF12;CCK;SPX;GRP;NPFF;PNOC
prerank,protein phosphatase regulator activity (GO:0019888),0.35060741253468186,0.9368152507158981,0.5561224489795918,1.0,1.0,12/53,12.78%,RCAN2;PPP2R1B;SET;SAG;PPP2R5A;CALM1;RCAN3;ENSA;EIF2AK2;DMPK;CABIN1;ARPP19
prerank,Tat protein binding (GO:0030957),0.47741217556864507,0.9366121895095875,0.5535714285714286,1.0,1.0,2/10,6.18%,ACTB;SMARCB1
prerank,phospholipase binding (GO:0043274),-0.36923982037352915,-0.9355456179878257,0.5141509433962265,0.8520055476990998,1.0,5/13,18.35%,PDPK1;PAFAH1B1;PRKN;DGKQ;BLNK
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2087338249022288,-0.9354228661805268,0.85,0.8468039128903488,1.0,85/269,24.02%,SNCAIP;SMAD3;ARRB1;UBXN7;FZD6;ATXN3;ITCH;SMAD6;POLR2A;CUL3;EGFR;XRCC5;RNF20;FOXO1;NFKBIA;NAE1;SHPRH;PML;DERL1;HSPA5;CASP8;PRR5L;HSP90AB1;SLF2;PCBP2;USP7;HERC2;BAG4;PRKAR2B;UQCRC1;PTPN22;MDM2;FBXO7;IKBKG;RNF31;PRKN;BAG1;TRIP4;AMBRA1;SLF1;UBC;BLZF1;RNF34;STUB1;STAT2;RTN4;DTX1;DTX3L;DBT;SLC22A18;PER1;CALR;SYT11;UBXN1;HGS;SMAD2;NEK6;GABARAPL2;HSPA9;WRAP53;CHEK2;RALB;PRKAR2A;SPOPL;ARRDC1;TRIB1;RPL11;ARIH1;SCAMP3;SUMO3;SUMO2;ABI2;HSPD1;UBB;AXIN1;DET1;UBE2B;TXNIP;PTPRN;YWHAZ;MAGEC2;USP25;TMBIM6;MAP1LC3A;CDKN1A
prerank,hexosyltransferase activity (GO:0016758),-0.22851301180969213,-0.9329871489151738,0.6521739130434783,0.8475879504509848,1.0,30/101,25.35%,TMTC1;TMTC2;MGAT4C;B4GALT1;CHSY1;DPY19L4;B4GALT6;GBE1;TMTC4;DPY19L1;MGAT4B;OGT;HEXA;B3GALNT1;PIGV;B4GALT4;CHPF2;B4GALT7;ALG1;GBA2;ALG12;B3GNT2;POMT1;GYG1;B3GALT2;LFNG;B4GALT3;GCNT1;MFNG;MGAT4A
prerank,neuropeptide receptor activity (GO:0008188),0.3925378167088674,0.9329580561425732,0.518463810930576,1.0,1.0,2/29,4.13%,NPY1R;TACR3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.3590373384245832,-0.9329230501636031,0.5667506297229219,0.8423946161867665,1.0,3/14,5.34%,SPOCK2;COL4A3;RECK
prerank,neuropeptide binding (GO:0042923),-0.33575198270409645,-0.9324729180976007,0.5315068493150685,0.8382673550772287,1.0,11/18,54.64%,GPR149;GPR37;NMUR2;OPRL1;SSTR2;SORL1;MC4R;SSTR1;OPRD1;NMUR1;OPRM1
prerank,phosphatase binding (GO:0019902),-0.22757675136409772,-0.9317967476596853,0.572463768115942,0.8345713152103318,1.0,30/105,20.81%,SMAD3;DLG1;MAPK14;CDH5;PXN;WNK1;EGFR;PTK2;MAGI2;CRY1;CTNNB1;MTMR4;PPME1;DZIP3;SIRPA;HSP90B1;SH3RF2;PDLIM4;SH3YL1;CRY2;PPP6R3;SMAD2;TERF2IP;SNX3;ANAPC4;STAT6;NFATC2;CEACAM1;CARHSP1;MVP
prerank,carboxypeptidase activity (GO:0004180),0.3695818238969135,0.9279925024111121,0.5583684950773559,1.0,1.0,4/35,7.32%,AGBL1;BLMH;CPA4;CPA3
prerank,pseudouridine synthase activity (GO:0009982),0.43892799925633885,0.9279754435170063,0.5506003430531733,1.0,1.0,5/13,18.21%,RPUSD3;PUS7L;RPUSD4;TRUB1;TRUB2
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.23775042021565085,-0.9266828210096749,0.625,0.8416381376618113,1.0,28/85,26.91%,PAFAH1B2;DDHD2;LYPLA1;ABHD5;ENPP2;CA2;PLA2G6;PLAAT3;NOTUM;GDPD1;ABHD12;ASPG;PLA2G7;ABHD3;LIPE;AARS1;GDE1;TARS2;PLA2G12A;APMAP;PNPLA6;ABHD6;LIPA;DAGLB;ABHD8;LYPLA2;PGLS;PNPLA2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.453819650154198,0.9263046760770496,0.5367647058823529,1.0,1.0,2/11,11.91%,SLC25A29;SLC22A5
prerank,metallocarboxypeptidase activity (GO:0004181),0.3893489383542358,0.9260353239178174,0.5460122699386503,1.0,1.0,3/26,7.32%,AGBL1;CPA4;CPA3
prerank,GTPase binding (GO:0051020),0.31106086903109204,0.9256956345451288,0.5993657505285412,1.0,1.0,45/194,14.68%,FLNA;RNF152;PLCE1;MYO9B;LCP1;RHOBTB3;STRN3;UNC13D;TBC1D20;TNFAIP1;BICD2;ARHGEF16;KIF3B;ARHGEF2;MTSS2;RUSC2;CAV1;NDRG1;RABGAP1;CYFIP1;RAPGEF6;PEX5L;EVI5;DAPK3;WHAMM;DENND10;PAK2;ARHGAP1;RRAGB;ANKFY1;RAB11FIP3;RAB11FIP4;DNM1L;SH3BP4;RHOH;AIMP1;XPO5;HPS4;MYO5B;TNPO3;IARS1;EPRS1;LRRK2;ANKRD27;RAB34
prerank,phosphatidylinositol binding (GO:0035091),0.3289748426179842,0.9243977615763472,0.5593607305936074,1.0,1.0,24/91,18.15%,MYO1E;ESYT2;ITPR1;HIP1;PITPNB;MAPT;MREG;ANKFY1;GAP43;DENND1A;GRAMD2A;WDR45;SNX13;SNX9;SNX17;PARD3B;SNX1;PITPNM2;SNAP91;PHF12;SNX4;ESYT1;ZFYVE16;RPH3A
prerank,sodium:proton antiporter activity (GO:0015385),-0.3885003252807867,-0.9237123889652946,0.5539906103286385,0.8426301258957023,1.0,5/11,25.69%,SLC9B2;SLC9A2;SLC9A6;SLC9A9;SLC9A5
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.36480536459258234,-0.9227485290015655,0.5741176470588235,0.8393928129155467,1.0,7/13,30.15%,AGPAT4;ABHD5;LPCAT2;AGPAT5;AGPAT1;LCLAT1;AGPAT2
prerank,transcription coactivator binding (GO:0001223),-0.3194961059388705,-0.9219550962769607,0.5674931129476584,0.8359719469808816,1.0,10/20,19.38%,SMAD3;MED25;AHR;ESR1;TEAD2;CCNT2;CIT;SMAD4;ZBTB17;THRB
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.2980673989282443,-0.9199721136800743,0.6072507552870091,0.8350021417574791,1.0,8/30,15.28%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC25A28;SLC39A1;SLC39A6
prerank,protease binding (GO:0002020),0.3315062118181756,0.9190982113528614,0.5770567786790266,1.0,1.0,16/99,12.43%,TTN;ITGA3;ADRM1;STIM1;ITGB1;BCL2;TP53;TIMP4;ITGB3;AMFR;SRI;ANXA9;LONP2;NFRKB;POLG;COL3A1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3832282603465951,-0.9177677501907014,0.5686274509803921,0.8348822510135857,1.0,4/11,12.19%,SGMS1;SGMS2;PTDSS2;GNPTAB
prerank,phospholipase activator activity (GO:0016004),0.46193688104192165,0.9176989277008674,0.5675675675675675,1.0,1.0,2/10,4.86%,CCL5;ARHGAP6
prerank,phosphoric diester hydrolase activity (GO:0008081),0.36887295505350126,0.9139845345838791,0.5608695652173913,1.0,1.0,4/35,3.59%,PLCE1;PLCB4;PLCL1;PLCXD1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.37041222979943544,-0.9138772892871097,0.5729847494553377,0.8383843885335934,1.0,6/12,32.37%,SULF1;ARSI;GALNS;SULF2;SGSH;ARSB
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.36827510516347106,0.9114112842008977,0.5668523676880223,1.0,1.0,9/34,14.66%,NDUFS1;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFA1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.36827510516347106,0.9114112842008977,0.5668523676880223,1.0,1.0,9/34,14.66%,NDUFS1;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFA1
prerank,ion channel activity (GO:0005216),0.32387093911477,0.9077259141246341,0.5948275862068966,1.0,1.0,11/80,12.48%,ASIC3;TRPC6;GRIN2C;PKD1L3;TRPV2;CALHM5;TRPM4;GRIK5;KCNK3;CHRNA7;TRPM2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4366554468808037,0.9010866298567429,0.5734024179620034,1.0,1.0,3/12,15.38%,TRAF3;TRAF5;STAT1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.42378322093678567,0.8997916147700723,0.6006493506493507,1.0,1.0,3/15,5.03%,SOCS5;SOCS6;SOCS4
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.29457187300211024,-0.8995843268483127,0.5961538461538461,0.8648451899964578,1.0,11/27,19.32%,DCUN1D3;ZMYM2;RNF144B;RNF217;RNF144A;PRKN;RNF125;SIAH1;TOLLIP;SIAH2;ARIH1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.34532436905850844,0.8990211914882386,0.5758354755784062,1.0,1.0,5/46,6.60%,LARGE1;EXT2;GCNT2;PIGA;RFNG
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.434976371835728,0.8971011679056724,0.5809352517985612,1.0,1.0,4/11,19.43%,AKR1B1;AKR1B10;RDH11;RDH13
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.44176716251520654,0.8944502508433394,0.5808270676691729,1.0,1.0,2/11,4.45%,NUDT7;NUDT4
prerank,single-stranded DNA helicase activity (GO:0017116),0.40132116287071234,0.8935699031162321,0.6070234113712375,1.0,1.0,3/19,8.60%,WRNIP1;CHTF18;HELQ
prerank,mRNA 5'-UTR binding (GO:0048027),-0.29698041667911124,-0.893469734820378,0.6456043956043956,0.873177846847448,1.0,6/24,18.72%,DDX3X;RPS13;RSL1D1;GNL3;FMR1;RPS7
prerank,GTPase activity (GO:0003924),0.30290422064958505,0.89329470309116,0.6547743966421826,1.0,1.0,39/192,16.94%,RASL12;RAP1A;RERG;GEM;RHOBTB3;GNAO1;GNAZ;NKIRAS2;RAP2C;TPPP;RRAS;RHOJ;RAB3A;ENTPD7;OPA1;RHOF;GNA12;GNG11;RRAGB;RAP2A;GFM2;DNM1L;GSPT1;MFN2;RHOH;DRG2;GBP2;LSG1;GNAQ;RAB14;LRRK2;DIRAS2;RAB8B;RHOG;DNM2;RHOT1;AGAP2;RAB8A;RAB38
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3471915189502401,-0.8930607229481318,0.5730858468677494,0.8689217270633475,1.0,6/14,35.53%,POP1;TSEN34;ELAC2;POP4;RPP38;RPP21
prerank,GTPase activator activity (GO:0005096),0.2921301185192118,0.8926760207222623,0.6990881458966566,1.0,1.0,52/313,11.68%,ARHGEF7;RAP1A;RALGAPA2;DLC1;TBC1D1;RGS6;KALRN;ABR;PLCE1;ARHGEF17;RASGRP2;DOCK8;MYO9B;ITSN1;ELMOD1;DOCK10;TBC1D20;ARHGAP10;ELMOD2;ARHGEF16;CHN1;ARHGEF2;LARS1;MTSS2;NUCB1;RABGAP1;RCC1L;RAPGEF6;RASGRP1;ARHGAP17;RALGAPA1;PLCB1;DNMBP;EVI5;RIN2;DENND10;ARHGAP39;ARHGAP30;ARHGEF4;RALGAPB;ARHGAP1;ASAP2;NPRL2;DOCK1;DNM1L;VAV1;DENND1A;TBCD;ARHGAP15;FRMD7;ARHGAP35;HTR2B
prerank,calcium:sodium antiporter activity (GO:0005432),0.44050119753102246,0.8922993287543254,0.5637342908438061,1.0,1.0,2/10,2.70%,SLC8A2;SLC8A1
prerank,alpha-tubulin binding (GO:0043014),0.3674612770373608,0.8904710935860871,0.5805084745762712,1.0,1.0,4/31,8.93%,DLEC1;TTLL7;EFHC1;WASHC1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.3857619993496615,0.8870345599649748,0.5858747993579454,1.0,1.0,4/21,15.30%,ANXA9;CHRNA7;CHRFAM7A;CHRNA4
prerank,neurexin family protein binding (GO:0042043),-0.38617224134429395,-0.8869441979924299,0.6233183856502242,0.87721188880025,1.0,4/10,17.13%,NLGN1;NLGN2;NLGN3;SYTL4
prerank,symporter activity (GO:0015293),-0.3818313063456533,-0.8868029889590174,0.5987124463519313,0.8724772485550432,1.0,3/10,28.37%,SLC5A5;MFSD2A;SLC5A6
prerank,histone methyltransferase binding (GO:1990226),-0.37153052199168973,-0.8861746073581269,0.6293859649122807,0.8687165744168218,1.0,2/11,7.19%,CTNNB1;HSP90AB1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.29634783818915134,0.8848183778994361,0.7054582904222451,1.0,1.0,28/254,9.57%,PRDM16;MEF2C;SMARCD3;NR1H4;ALX4;NR4A1;GABPA;PRRX1;HINFP;FOSL2;VEZF1;OSR2;SP7;KLF7;MEF2A;DBP;FOXJ3;KLF15;TP53;GRHL1;HOXC4;AR;SOX9;RELA;ZFP62;PPARA;NR4A2;HIF1A
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.35934947426444896,-0.8837212973809115,0.6309794988610479,0.8691286102081308,1.0,3/12,3.31%,CISD2;AOX1;XDH
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.35505199955268474,0.8807612597145279,0.6074498567335244,1.0,1.0,9/34,15.16%,SMYD1;SETD6;SETD3;NSD3;ATPSCKMT;VCPKMT;N6AMT1;KMT5B;EEF1AKMT2
prerank,3'-5' DNA helicase activity (GO:0043138),-0.3323789098704719,-0.8795659685414756,0.6423357664233577,0.8730975978864051,1.0,3/16,11.84%,NAV2;FBH1;BLM
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.4410587506847049,0.8794128946992072,0.5878260869565217,1.0,1.0,2/10,12.81%,DUSP5;DUSP16
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.4410587506847049,0.8794128946992072,0.5878260869565217,1.0,1.0,2/10,12.81%,DUSP5;DUSP16
prerank,lipoprotein particle receptor binding (GO:0070325),-0.28664810867427737,-0.8787267797796949,0.6802325581395349,0.8697602997103353,1.0,4/27,12.91%,LRP1;APOE;SYT1;HSP90B1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4110637510441492,0.8774111446423125,0.5985915492957746,1.0,1.0,7/14,21.32%,NDUFS1;ACO2;RSAD1;ISCA2;IREB2;NFU1;RSAD2
prerank,death receptor activity (GO:0005035),0.42473121199117964,0.8771246630778987,0.6221441124780316,1.0,1.0,3/11,13.74%,TNFRSF11A;TNFRSF25;TNFRSF10B
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.22588930467023566,-0.8766677736675581,0.7317073170731707,0.8690191229448901,1.0,19/78,23.53%,USP46;USP11;CAPNS1;CTSL;CTSH;CASP8;USP7;USP12;CTSB;USP29;CASP9;USP37;CAPN10;USP24;CASP4;USP10;CTSS;CASP12;USP25
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.30654537896332984,-0.8755123461535416,0.6649076517150396,0.866506287396128,1.0,9/20,31.76%,AGPAT4;LPGAT1;ABHD5;LPCAT2;AGPAT5;AGPAT1;LCLAT1;AGPAT2;DGAT2
prerank,poly(U) RNA binding (GO:0008266),-0.31169375660826965,-0.8735788920885713,0.6345609065155807,0.865493793001432,1.0,6/20,10.44%,RBMS1;RBMS2;KHDRBS1;SSB;PABPC1;DAZAP1
prerank,peptidase inhibitor activity (GO:0030414),-0.27211666388052713,-0.8719392606507271,0.6655290102389079,0.8638652329710992,1.0,6/33,10.66%,TFPI;PROS1;RECK;ITIH2;RENBP;SERPIND1
prerank,thioesterase binding (GO:0031996),0.42998464828287397,0.8718589185560982,0.5891891891891892,1.0,1.0,4/11,17.43%,TRAF3;TRAF5;HAUS7;ADRA2A
prerank,cGMP binding (GO:0030553),0.4247548859732094,0.8696116890322161,0.6064400715563506,1.0,1.0,1/11,2.77%,PDE5A
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3312054774395542,0.8682561301622639,0.6243455497382199,1.0,1.0,11/49,12.81%,DUSP5;PLCXD1;ACP3;PRUNE1;LHPP;DUSP3;SACM1L;PPP1CB;PPP1CA;SBF1;DUSP16
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.34682856756414704,0.8679177810699571,0.6275579809004093,1.0,1.0,14/37,20.57%,NARS2;HARS2;LARS1;IARS2;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2;GARS1;AARS2;CARS2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.32266349489611973,0.8638335081358907,0.6414141414141414,1.0,1.0,19/57,20.67%,NDUFS1;COX7A2L;NDUFA2;COX8A;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFA1;CYB561A3;UQCRFS1;UQCRH;COX5B;NDUFV3;UQCRQ;NDUFS4;COX6A1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.35271343773358865,-0.8589358048888713,0.6384439359267735,0.8854312371429774,1.0,2/12,6.71%,GAB2;FRS2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.367627286776434,0.8584478293334463,0.6318840579710145,1.0,1.0,8/26,12.78%,PABIR1;SET;SAG;PPP1R14C;ENSA;PPP1R14A;CABIN1;ARPP19
prerank,single-stranded DNA binding (GO:0003697),-0.21741229969911777,-0.8578897757189674,0.8029197080291971,0.8824811182401066,1.0,31/93,27.81%,RBMS1;HMGB1;STN1;TDP2;WDR48;FUBP1;FBH1;PCBP2;ERCC5;SAMHD1;PURB;BLM;RTF1;HMCES;CTC1;SSBP2;CRY2;PARK7;PMS2;HSPD1;POLR2H;POLR3C;NUCKS1;IGHMBP2;ERCC1;RAD23B;ERCC4;TOP1;HMGB2;RPA3;WBP11
prerank,fibroblast growth factor binding (GO:0017134),-0.29231681175446356,-0.8571450522091434,0.6587301587301587,0.8790835005443617,1.0,10/21,30.40%,RPS19;ITGAV;FGFR2;FIBP;FGFR4;KL;GPC1;CEP57;FGFRL1;FGFBP3
prerank,acylglycerol lipase activity (GO:0047372),-0.3556626293966218,-0.8551632969559719,0.6505494505494506,0.8780810807596254,1.0,4/11,23.17%,ABHD12;ABHD3;LIPE;ABHD6
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.2786839969408881,-0.8544016025547758,0.6804733727810651,0.8746595388693683,1.0,9/27,17.16%,SLC22A8;SLC26A7;SLC39A8;SLC22A6;SLC25A14;SLC5A5;SLC26A2;SLC25A30;SLC25A11
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.35051158119389864,-0.8541247957527195,0.6875,0.8704487499633823,1.0,12/12,64.98%,ELOVL4;OPN3;GPR88;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4;GPR52
prerank,cysteine-type peptidase activity (GO:0008234),0.30586642211160775,0.8515896819371154,0.6666666666666666,1.0,1.0,13/73,14.90%,TINAGL1;USP2;BLMH;CAPN2;USP1;ATG4D;USP13;USP50;ATG4A;USP35;USP20;USP30;USP42
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.35885278500120377,0.8507474956156957,0.625,1.0,1.0,2/26,3.27%,CHSY3;CSGALNACT1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.35478136000469884,0.8494379638699235,0.634703196347032,1.0,1.0,6/27,14.44%,POLR2L;POLR2I;POLR2G;POLR1H;POLR2J;POLR3K
prerank,palmitoyltransferase activity (GO:0016409),0.36120931268953305,0.8488492530335231,0.6339285714285714,1.0,1.0,11/28,18.76%,GOLGA7B;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;ZDHHC13;ZDHHC4;ZDHHC5;ZDHHC8;ZDHHC3
prerank,vitamin D receptor binding (GO:0042809),-0.3295999132379887,-0.8448938837515295,0.6938271604938272,0.883026603003885,1.0,9/14,29.77%,MED13;MED17;SNW1;MED24;MED16;MED30;TAF7;RXRA;THRAP3
prerank,SUMO transferase activity (GO:0019789),0.38883219639316025,0.8447202393115779,0.6544502617801047,1.0,1.0,7/16,19.31%,PIAS4;CBX4;PIAS2;MUL1;TRIM28;PIAS1;UBE2I
prerank,SH3 domain binding (GO:0017124),0.31545795757704065,0.8405423580882391,0.6814268142681427,1.0,1.0,6/62,7.61%,ENAH;MYPN;SYNJ2;MAPT;DAB2IP;RAD9A
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4136329399949787,0.8370095115316674,0.6427289048473968,1.0,1.0,11/11,58.67%,HCN2;CNGA1;KCNA10;CNGA3;CNGA4;CNGA2;HCN1;AQP1;CNGB3;HCN4;CNGB1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.41772373122192935,0.8359906273034253,0.6397188049209139,1.0,1.0,3/11,10.33%,PABIR1;PPP1R14C;PPP1R14A
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.38193227424641946,0.8358740773055882,0.6516464471403813,1.0,1.0,5/16,17.85%,MTMR7;SACM1L;MTMR14;PTEN;MTMR3
prerank,transition metal ion binding (GO:0046914),0.27144558008231356,0.8351293017408886,0.8449144008056395,1.0,1.0,33/397,7.40%,AOC3;CRIP1;PAPPA2;TRIM54;MSRB3;CSRP1;DYRK2;POLR2L;LIMS1;TRIM2;ADCY2;LARGE1;LOXL2;RBAK;ITGB1BP2;SIRT3;ALOX5;ATAD3A;PIAS4;ARHGEF2;RNF7;ETHE1;KLF7;LNPEP;TYW5;RNPEP;SUV39H2;TP53;CALB1;PTPN1;ABCE1;RASGRP1;ENPEP
prerank,poly-pyrimidine tract binding (GO:0008187),0.3628881543318989,0.8349309705239213,0.6526946107784432,1.0,1.0,7/23,11.70%,RBMS3;MCRS1;ATXN1;U2AF2;DIS3L2;HNRNPU;HNRNPC
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3454467265898664,0.8328663772044148,0.6596385542168675,1.0,1.0,8/28,15.49%,RPS6KA2;MAP2K1;MAP2K3;SGK1;LRRK2;PRKAA2;PRKACA;MAP2K4
prerank,cytokine receptor activity (GO:0004896),0.30032696402817366,0.8326088754768756,0.7154861944777912,1.0,1.0,9/83,10.76%,LIFR;CRLF1;FZD4;IL12RB2;IL10RA;IL12RB1;GPR17;IL13RA1;GFRA1
prerank,receptor ligand activity (GO:0048018),0.27419938409282796,0.831662193740559,0.7913669064748201,1.0,1.0,17/245,7.86%,NTF3;FGF1;PDGFB;SEMA5A;CRLF1;THPO;GREM2;JAG1;IL2;TNFSF13B;TGFB3;CCL5;SEMA6C;VEGFA;GDNF;AREG;TGFB2
prerank,nucleotidase activity (GO:0008252),0.3797995388423121,0.8313714043698507,0.6706896551724137,1.0,1.0,5/15,19.79%,ACP3;NT5C2;NT5M;NT5C3A;NT5C
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.3966478854385179,0.830689363989834,0.6538461538461539,1.0,1.0,2/12,5.14%,LTBP1;BMPR1A
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.39090453039882106,0.8300919916489741,0.653781512605042,1.0,1.0,2/14,15.73%,DHRS3;RDH11
prerank,rRNA binding (GO:0019843),0.33035690450162464,0.8299295928337737,0.6885474860335196,1.0,1.0,6/42,10.52%,CAVIN1;FASTKD5;RCC1L;CIRBP;RPL5;MRPL16
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.33092291727992595,0.8292859185956757,0.6834239130434783,1.0,1.0,6/42,8.93%,CCNA2;CCND2;CCNQ;HEXIM1;CCND1;CCNT1
prerank,phospholipase activity (GO:0004620),0.30830316950245346,0.8286917016691664,0.6950617283950618,1.0,1.0,5/67,3.65%,PLCE1;PLCB4;LPL;PLCL1;PITPNM3
prerank,myosin II binding (GO:0045159),0.40360109618728984,0.8273346362124416,0.6423220973782772,1.0,1.0,1/10,2.58%,MYL3
prerank,protein phosphorylated amino acid binding (GO:0045309),0.3206166310877567,0.8255721340377845,0.675531914893617,1.0,1.0,10/42,13.44%,BCAR3;SHD;IRS1;FBXW7;PIN1;NEDD4;SAMSN1;VAV1;LDLRAP1;NCK2
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3499044585526887,-0.8243868526071195,0.6621315192743764,0.916171837194636,1.0,4/10,13.97%,ATF2;NAA50;EP300;NAA60
prerank,phospholipase A2 activity (GO:0004623),0.35129663083926477,0.8239064777603927,0.6690962099125365,1.0,1.0,6/26,17.31%,PLA2G3;PLB1;PNPLA3;PLA2G4A;PLA2G4C;PRDX6
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.30527764309698635,-0.8224687818877162,0.7041564792176039,0.9148549940031203,1.0,4/17,12.98%,PPT1;ACOT8;ACOT9;PLA2G6
prerank,lipase activity (GO:0016298),-0.2381635114007311,-0.8211744617655428,0.7992700729927007,0.9122976976450246,1.0,14/43,27.12%,DDHD2;PLA1A;LYPLA1;SEC23IP;ABHD5;DDHD1;ABHD12;ABHD3;LIPE;ABHD6;LIPA;DAGLB;PNPLA2;PNPLA8
prerank,methyltransferase activity (GO:0008168),-0.23492534814833707,-0.8203599064862882,0.7734375,0.9089573538626221,1.0,23/46,38.04%,COQ5;PRMT3;AS3MT;METTL3;EEF1AKMT1;TRMT11;BUD23;ARMT1;NSUN3;RRP8;SUV39H1;FTSJ3;COQ3;AMT;NDUFAF7;METTL27;GCSH;MRM2;BCDIN3D;NTMT1;GAMT;DNMT3B;PRMT8
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.3553511970233121,-0.8176927831944184,0.6904761904761905,0.9091144302542793,1.0,2/10,5.95%,GNAS;SHANK3
prerank,phosphotyrosine residue binding (GO:0001784),-0.24216974068621286,-0.815719176066891,0.7857142857142857,0.907899688787844,1.0,6/37,6.44%,GRB2;PTPN11;RASA1;PIK3R3;VAV2;PLCG2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.3902638312028501,0.8149515177790561,0.6471600688468159,1.0,1.0,4/13,17.14%,IDI1;SREBF2;ECI1;MIF
prerank,G protein-coupled amine receptor activity (GO:0008227),0.35306546192291854,0.8145893213347987,0.6774193548387096,1.0,1.0,3/22,11.68%,HTR1B;HRH3;HTR2B
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.35306546192291854,0.8145893213347987,0.6774193548387096,1.0,1.0,3/22,11.68%,HTR1B;HRH3;HTR2B
prerank,serotonin receptor activity (GO:0099589),0.35306546192291854,0.8145893213347987,0.6774193548387096,1.0,1.0,3/22,11.68%,HTR1B;HRH3;HTR2B
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.329067317537344,0.8144210288404914,0.685595567867036,1.0,1.0,6/33,8.61%,UBA2;DCUN1D2;AUP1;DCUN1D1;RNF180;PPARA
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.37857949467677243,0.8141961195510504,0.6878130217028381,1.0,1.0,2/15,5.54%,SLC4A8;SLC4A3
prerank,general transcription initiation factor binding (GO:0140296),-0.2698968262381586,-0.813487272565548,0.7735849056603774,0.906891491684737,1.0,8/25,15.24%,YEATS2;AHR;ESR1;DR1;PSMC5;PSMC2;TAF12;TAF13
prerank,four-way junction DNA binding (GO:0000400),-0.296572558396471,-0.8117666950174504,0.7281795511221946,0.905180820950362,1.0,6/17,28.16%,HMGB1;BLM;MSH6;RAD51C;HMGB2;XRCC2
prerank,nuclease activity (GO:0004518),-0.2234533328222907,-0.8115171741056252,0.8361344537815126,0.9010081208669518,1.0,19/52,29.27%,REXO5;MRE11;N4BP2;ERCC5;SAMHD1;DIS3;RNASE4;REXO1;ENPP1;ISG20L2;ZC3H12A;NME1;RNASEL;AEN;EXOG;SND1;OGG1;DNA2;PDE12
prerank,heme binding (GO:0020037),0.29908338515217797,0.8081415727200078,0.724390243902439,1.0,1.0,15/65,16.60%,GUCY1B1;PTGIS;HMOX2;TBXAS1;SDHC;PXDN;HEBP2;NR1D1;THAP4;RSAD1;SLC48A1;DGCR8;NOS1;JAK2;PGRMC1
prerank,protein kinase C binding (GO:0005080),0.3185901242937031,0.8074318133546403,0.7250996015936255,1.0,1.0,7/43,12.74%,PDLIM5;HDAC9;IRS1;PLEK;ADCY6;TOP2B;CAVIN3
prerank,outward rectifier potassium channel activity (GO:0015271),-0.3408725040780176,-0.8051361132200527,0.7322175732217573,0.907371709621803,1.0,3/11,9.85%,KCNK2;PKD2;KCND3
prerank,glutamate receptor binding (GO:0035254),0.36638671801170614,0.8030727942763841,0.6761565836298933,1.0,1.0,5/17,14.84%,HIP1;NSF;HOMER1;SHANK2;SHISA6
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3669506059235884,0.8025311930265695,0.6722408026755853,1.0,1.0,4/16,11.91%,SLC44A1;SLC7A8;SLC25A26;SLC22A5
prerank,chloride transmembrane transporter activity (GO:0015108),0.36214531027160746,0.7999501560370211,0.6915739268680445,1.0,1.0,2/16,5.96%,SLC4A8;CLCN6
prerank,nucleosomal DNA binding (GO:0031492),0.3529391398364867,0.7993551806979743,0.6811819595645412,1.0,1.0,7/21,18.88%,H1-0;ACTB;SMARCB1;HNRNPC;CHD4;HDAC1;ACTL6A
prerank,neuropeptide hormone activity (GO:0005184),-0.2698443737888623,-0.797000383871312,0.7859078590785907,0.9161989907118779,1.0,19/22,64.22%,PPY;ADCYAP1;PENK;CCK;SPX;GRP;NPFF;PNOC;NMB;AGRP;VIP;CRH;GAL;CALCB;UCN;NPPA;GHRH;HCRT;QRFP
prerank,zinc ion binding (GO:0008270),0.25980242020964145,0.7937453448031211,0.8682328907048008,1.0,1.0,23/293,7.40%,CRIP1;PAPPA2;TRIM54;MSRB3;CSRP1;POLR2L;LIMS1;TRIM2;RBAK;ITGB1BP2;SIRT3;ATAD3A;PIAS4;ARHGEF2;KLF7;LNPEP;RNPEP;SUV39H2;TP53;CALB1;PTPN1;RASGRP1;ENPEP
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.31643556988764604,0.7930334601469208,0.6954022988505747,1.0,1.0,12/34,19.35%,TAF1;UBE2W;UBE2F;UBE2E1;UBE2D1;AKTIP;UBE2J1;UBE2K;UBE2L6;UBE2A;UBE2I;UBE2Q1
prerank,nuclear export signal receptor activity (GO:0005049),0.3923854894296872,0.7930104424093681,0.6935779816513762,1.0,1.0,3/11,16.83%,RANBP17;XPO5;XPO1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.27262100262398636,-0.7906375069873781,0.7471264367816092,0.9219174232788847,1.0,9/20,35.57%,MRE11;RAD50;ERCC5;ERCC1;ERCC4;EXOG;DNA2;ENDOV;DCLRE1C
prerank,epidermal growth factor receptor binding (GO:0005154),0.33805632944972563,0.7896207825409245,0.7213622291021672,1.0,1.0,6/25,16.94%,HIP1;ATXN2;AREG;HBEGF;SNX1;SNX4
prerank,protein kinase regulator activity (GO:0019887),0.28232555198691067,0.7894315578705973,0.7654028436018957,1.0,1.0,21/95,17.25%,FGF13;CCNA2;CCND2;CCNQ;HEXIM1;TPX2;ANKRD54;CCND1;PRKAR1B;CCNT1;PARVA;TAOK3;DNAJC3;CCNJL;ELP3;AGAP2;MT3;KIDINS220;CCNF;MARK2;FAF1
prerank,ubiquitin-specific protease binding (GO:1990381),-0.2841131771168069,-0.7893538959929292,0.8,0.9194897213218656,1.0,5/19,19.27%,DERL1;PRKN;SART3;SYVN1;PARK7
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3570974806246778,0.7892249749126942,0.717628705148206,1.0,1.0,3/18,5.03%,SOCS5;SOCS6;SOCS4
prerank,lysine N-methyltransferase activity (GO:0016278),0.3423180958277346,0.7881219862219311,0.7211538461538461,1.0,1.0,5/20,15.16%,SETD6;SETD3;ATPSCKMT;VCPKMT;EEF1AKMT2
prerank,protein kinase inhibitor activity (GO:0004860),0.3069523888990967,0.7880722065738192,0.7190860215053764,1.0,1.0,6/42,13.59%,INKA2;HEXIM1;PARVA;TAOK3;CEP43;DNAJC3
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3921263822811506,0.7876378890283483,0.6892857142857143,1.0,1.0,2/10,8.20%,NAA25;NAA20
prerank,dynactin binding (GO:0034452),0.3891300247062862,0.7838716445183399,0.6979522184300341,1.0,1.0,2/12,6.17%,BICD2;MAPT
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.32056433430561626,-0.7828986103278598,0.7551487414187643,0.9251189185854901,1.0,2/12,4.81%,CYFIP2;DCPS
prerank,syntaxin binding (GO:0019905),0.28937308641289244,0.7797212843259085,0.7410714285714286,1.0,1.0,3/61,4.63%,STXBP2;SYPL2;SYT10
prerank,acetyltransferase activity (GO:0016407),0.3251829231332665,0.7791072153268219,0.7118155619596542,1.0,1.0,5/31,10.39%,NAT10;SAT2;NAT8L;NAT8;NAT14
prerank,RNA binding (GO:0003723),0.2532601828378977,0.7774128302840666,0.988,1.0,1.0,328/1321,20.44%,FLNA;SORBS2;MAP3K20;RBPMS;ACTN1;NOL6;RBPMS2;XIRP1;LSM8;ACTN4;RPL3L;CSRP1;CAVIN1;TNS1;SYNE1;KHDRBS3;MYH9;HNRNPR;VIM;HSD17B10;NUDT7;RAVER2;FASTKD5;RBM38;SAMD4A;DENR;MRPS31;H1-0;MRPL13;NAT10;PRPF38B;RBMS3;PARN;MCRS1;UTP14A;HARS2;RPUSD3;DDX23;NUDT4;SRP68;WDR33;RAD51AP1;UPF1;PCF11;CSDE1;ZNF638;CNOT4;MYO18A;TYW5;SF3B5;MTDH;POLR2G;TRMT10C;APEH;ATXN2;U2AF2;FAM32A;MYBBP1A;EIF1;MAPT;CHD2;WDR46;TERT;PARP1;RCC1L;HEXIM1;KTN1;RPS27L;PTPN1;CIRBP;ZCCHC7;RPL8;SFPQ;YTHDF2;FKBP3;RPF1;RCAN3;PA2G4;PPARGC1A;RTCB;CLNS1A;WDR36;PPARGC1B;CELF1;REXO4;DICER1;GOT2;RPS19BP1;DUSP14;MRPL43;SRSF4;FASTKD1;NAF1;PYM1;SRRM3;API5;PSTK;GPKOW;MBNL2;MRM1;PWP2;EIF4A1;MRPS35;MRPS28;FUS;LONP1;TDRD3;PPIE;ZC3H11A;PKN2;SEPSECS;LRRFIP1;MRPL45;RBM19;SECISBP2L;RPL5;SAMSN1;HADHB;SRP72;MRPL21;DDX59;MRPL23;PTBP2;RBM8A;KIF1C;MBNL1;U2AF1;EIF3E;DHX8;HNRNPU;PPP1R10;RPS23;MRPL16;EIF2AK2;EIF5A;TFB2M;ROCK2;CCT3;OTUD4;SRSF10;ALDOA;DDX1;FNDC3B;GSPT1;DDX25;RBM3;DCP1A;SF3A3;BAZ2A;NOP58;HNRNPC;NFX1;PSPC1;RBM6;EIF3H;MRPL9;KPNA2;YTHDC2;MAK16;DRG2;ALG13;SRRM1;AIMP1;TSFM;XPO5;DROSHA;RBM27;CPEB3;COL14A1;SF3B2;SF3B1;DCP1B;ZCRB1;OASL;NUFIP2;PCBP3;ZC3H4;MRPL42;NSUN2;ZFP36L1;CPNE3;RBM25;DXO;RPUSD4;TRIM28;CSNK1E;DHX30;SON;MTCL1;DGCR8;SYNCRIP;RPL15;TMSB4X;MAP4;GIGYF2;NUP98;SARS2;G3BP1;DDX55;CCDC9B;SRP19;CWC22;GDI2;EPRS1;IMP4;DDX56;EDF1;BZW1;EIF4E;STAU2;UBA1;KARS1;GLRX3;FASTKD2;SRPK2;RBM15;TEP1;NOL4;SF1;NANOS1;LAS1L;DDX18;PELP1;RFTN1;IREB2;NELFCD;RPL22;SARS1;DHX32;LSM10;SF3A1;PUF60;STAT3;SEC61B;ANXA11;FARS2;FIP1L1;PRRC2C;WBP4;ETF1;RPL31;IMMT;RBM45;MRPL14;DHX9;WDR6;DDX49;ACIN1;MRPL4;RPS6;MARK2;EIF4G2;USP36;BOP1;FKBP4;LUC7L;EIF2AK4;PDCD11;RPS17;RBM33;FAM98B;CEBPZ;EEF2;DHX29;FAM120C;MRPS21;NAP1L4;TRUB2;NDUFV3;AKAP1;HNRNPUL2;RBM14;MDH2;HDLBP;SNRPD3;TEFM;FRG1;MRPL40;MRPL22;LGALS1;EXOSC10;CMSS1;RTCA;N4BP1;TRMT6;HABP4;NIFK;UCHL5;RPS27A;SUMO1;CLTC;UBE2I;NTPCR;RPS14;PKM;KIN;SNIP1;PRKRA;ILF3;AARS2;QKI;RPGR;AGO1;SLC4A1AP;ADARB1;ZRANB2;PRMT1;TIAL1;PPRC1;SPATS2L;CDK13;PNN;JUN;SRP14;SERBP1;NSUN5;MRPS14;DDX10;ERI1;YTHDC1;WDR43;DHX37;NSRP1;CS;C1QBP;PRR3;EIF2S1;EIF2A
prerank,Hsp90 protein binding (GO:0051879),-0.2362776278245236,-0.77458033500482,0.8493589743589743,0.9330976614710219,1.0,12/33,25.49%,SLC12A2;USP19;NR3C1;AHR;STUB1;ERN1;KDR;NPAS2;HSF1;TELO2;AHSA1;CSNK2A1
prerank,anion:anion antiporter activity (GO:0015301),-0.2875666721975749,-0.7741578551852736,0.8098958333333334,0.9292299203748593,1.0,4/17,17.16%,SLC26A7;SLC4A2;SLC26A2;SLC25A11
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3621000039023553,0.7724031456781446,0.7125850340136054,1.0,1.0,3/13,13.68%,DICER1;SLX4;DNASE1L1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2530396659488589,0.772187609022756,0.973,1.0,1.0,121/831,16.13%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ACTN4;ZFHX3;TBX2;NR1H4;EBF1;ZEB2;ALX4;RORA;NR4A1;EBF2;SIM2;GABPA;PRRX1;ETS2;HEYL;TEAD3;IRX5;HINFP;ZNF436;FOSL2;RBAK;NACC2;PRDM1;NR2F2;NR2C1;VEZF1;OSR2;SP7;KLF7;TBX18;KCNIP3;MEF2A;GBX1;KLF16;DBP;FOXJ3;KLF15;JUND;TAF1;CHD2;TP53;RXRG;GRHL1;ZNF418;ZBTB38;HOXC4;AR;ZFP28;ZNF431;SOX9;SNAI2;HSF4;RELA;ZFP62;CUX2;ZKSCAN4;PPARA;BBX;CARF;NR4A2;SKI;NR1D1;LRRFIP1;ZBTB33;HIF1A;ZBTB41;HNRNPU;ZNF3;NR2C2;TEAD1;SREBF2;RUNX1;RB1;ATF3;HOXC8;NKX6-1;ZKSCAN1;ZBTB7A;NFX1;ESRRA;NR6A1;POU3F3;MED8;ZBTB10;ZNF83;ZFP69;MXD4;BCL6;IKZF1;CASZ1;MEF2B;FOXJ1;ZBTB5;RFX7;ZKSCAN7;CLOCK;MTA1;ZBTB4;SP4;RFX1;EBF3;MLXIPL;KLF6;HOXB2;ZSCAN22;STAT1;HOXC5;NR5A1;RFX3;SARS1;ZSCAN18;SP1;STAT3;IKZF4;ZBTB9;CALCOCO1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.34331764389180086,0.7712393243593177,0.7466666666666667,1.0,1.0,7/21,19.82%,CDK6;CDK7;CDK12;CDK15;CDK14;CDKL2;CDK13
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.34331764389180086,0.7712393243593177,0.7466666666666667,1.0,1.0,7/21,19.82%,CDK6;CDK7;CDK12;CDK15;CDK14;CDKL2;CDK13
prerank,amyloid-beta binding (GO:0001540),0.2762471639703374,0.7710116700125978,0.7775061124694377,1.0,1.0,14/79,16.81%,CD36;APBA1;FZD5;FZD4;ITM2C;TGFB2;CACNA1B;CHRNA7;CLU;LDLRAP1;ATP1A3;HSPG2;PGRMC1;CLSTN1
prerank,NAD+ binding (GO:0070403),0.3751253609153443,0.7701400776587052,0.7116666666666667,1.0,1.0,4/12,16.51%,SIRT3;SIRT2;HADH;SIRT6
prerank,RNA stem-loop binding (GO:0035613),-0.31602140745946417,-0.7676077294685044,0.7753086419753087,0.9340313169761757,1.0,5/12,20.20%,DDX3X;RC3H2;ZC3H12A;FMR1;METTL16
prerank,DNA binding (GO:0003677),0.2506820807424258,0.7661810108271222,0.97,1.0,1.0,97/694,13.68%,SOX6;PRDM16;HEY2;TBX2;NR1H4;ZEB2;ALX4;TRNP1;RORA;MLF1;NR4A1;SIM2;ETS2;ARID5B;CGAS;HINFP;BRIP1;H1-0;CHRAC1;RAD51AP2;SIRT3;GTF2H4;ARID1A;NR2F2;NR2C1;BCL2;GTF3C4;RAD51AP1;OSR2;CBFB;SP7;ZNF638;MEF2A;POLR2G;FOXJ3;MYBBP1A;MBD5;TAF1;MAPT;SMARCB1;CHD2;ARID5A;TERT;TIPIN;TP53;GRHL1;HDGFL3;SFPQ;PPARGC1A;MBD4;TDP1;CHTF18;REXO4;ERCC6;SOX9;SNAI2;RELA;KMT2D;CUX2;PPARA;MSL3;CARF;CCNT1;LONP1;NR4A2;LRRFIP1;ZBTB33;HIF1A;CRLF3;DEDD2;ZDHHC1;SYCP2;HNRNPU;ZNF3;MCMDC2;NR2C2;TEAD1;POLD1;ZBTB7A;ESRRA;POLG;RBM6;TSG101;LIN9;CSRNP3;HDGFL2;DEDD;NR6A1;POU3F3;SMARCA5;OASL;BCL6;CHD4;IKZF1;FOXJ1;TRIM28;DNASE1L1
prerank,ribosomal small subunit binding (GO:0043024),-0.2857670419995249,-0.7648198610886423,0.8038740920096852,0.9335304640268881,1.0,2/17,2.55%,CPEB2;DDX3X
prerank,endopeptidase activity (GO:0004175),0.2511421505742789,0.7647093661414668,0.8802456499488229,1.0,1.0,32/257,15.09%,TMPRSS4;MMP17;ADAMTS14;ADAMTS5;KLK2;ADAMTS19;USP2;APEH;AFG3L2;TRABD2B;ADAM17;USP1;MASP2;MIPEP;PSMB1;MBTPS1;THSD4;PHEX;ADAMTS20;USP13;ADAMTS16;PSMB2;DDI2;PMPCB;USP35;USP20;USP30;ADAM19;PSMB7;USP42;PCSK4;ADAMTSL4
prerank,N-acyltransferase activity (GO:0016410),0.31227109370996553,0.7620177980546256,0.7082728592162555,1.0,1.0,6/32,10.39%,NAT10;SAT2;NAT8L;NAT8;CERS1;NAT14
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2526253837822224,0.7611223472667169,0.884102564102564,1.0,1.0,31/232,11.71%,TRIM54;RNF152;TRIM55;TRIM63;TRIM2;FBXL22;RNF150;PDZRN3;RNF114;ASB2;UBR5;ASB1;PIAS4;RNF7;CBLL1;NEURL4;NEDD4;RNF180;TRIM68;CBX4;NEURL1B;UHRF2;AMFR;TRIM7;NHLRC1;FBXO6;PELI2;UBE2D1;PIAS2;TRIM35;NFX1
prerank,RNA polymerase II complex binding (GO:0000993),0.3128417339343114,0.7601229529287868,0.7412280701754386,1.0,1.0,11/32,22.32%,SCAF1;PCF11;HNRNPU;URI1;ELOF1;DHX9;BRD4;AGO1;WDR43;RPRD1A;CCAR2
prerank,signal sequence binding (GO:0005048),0.30270649110522746,0.7598586854354907,0.7695530726256983,1.0,1.0,8/35,14.38%,CABP1;KPNA4;PEX5L;NUP153;RANBP6;KPNA2;KPNA3;IPO4
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3595486212333332,0.7587115738343665,0.7477313974591652,1.0,1.0,3/12,7.48%,DAB2IP;VEGFA;ITGB3
prerank,retinoic acid binding (GO:0001972),0.37252081676076737,0.7549013357915728,0.7081081081081081,1.0,1.0,1/12,4.32%,NR2F2
prerank,DNA polymerase binding (GO:0070182),-0.27326917950796814,-0.7543714809934658,0.8020050125313283,0.943960233162487,1.0,5/18,17.92%,HMGB1;HSP90AB1;FANCI;CDK2AP1;SMG6
prerank,pre-mRNA binding (GO:0036002),0.31626852278857115,0.7531654576156043,0.7598784194528876,1.0,1.0,5/28,10.29%,RBM24;U2AF2;CELF1;U2AF1;HNRNPU
prerank,protein kinase activator activity (GO:0030295),0.28089431314829233,0.7492960420699034,0.7843137254901961,1.0,1.0,7/60,9.22%,FGF13;FAM20A;CALM1;TPX2;ERCC6;MAP2K1;PAK2
prerank,GTPase regulator activity (GO:0030695),0.2509488034963586,0.7481989915400186,0.8744769874476988,1.0,1.0,49/212,16.77%,RALGAPA2;DLC1;TBC1D1;RGS6;ABR;MYO9B;ELMOD1;TBC1D20;ARHGAP10;ELMOD2;CHN1;LARS1;MTSS2;RABGAP1;ARHGAP17;RALGAPA1;PLCB1;EVI5;RIN2;ARHGAP39;ARHGAP30;RALGAPB;ARHGAP1;ASAP2;NPRL2;DOCK1;DNM1L;SH3BP4;TBCD;ARHGAP15;RHOH;ARHGAP35;HTR2B;BCR;ARHGAP32;GNAQ;RGS5;LRRK2;ARHGAP24;IPO7;RUNDC1;TBC1D22B;ARHGAP26;AGAP2;RASGRP3;RGS10;VAV3;PREB;TBC1D12
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3633379163683805,0.7472934635884837,0.7366482504604052,1.0,1.0,5/11,18.81%,UBR5;UBE4A;AMFR;UBE2K;ANAPC11
prerank,ribonuclease P RNA binding (GO:0033204),-0.3193924623226452,-0.747281193905225,0.7973568281938326,0.949195635418375,1.0,5/10,43.56%,POP1;POP4;RPP38;RPP21;POP7
prerank,insulin-like growth factor binding (GO:0005520),0.348680615905107,0.7463028580724581,0.740484429065744,1.0,1.0,4/15,7.48%,IGFBP5;IGFBP4;IGF2R;ITGB3
prerank,single-stranded RNA binding (GO:0003727),-0.21825660262666186,-0.7460320410856021,0.8801652892561983,0.9462427194711818,1.0,6/43,11.36%,AGO3;DDX3X;AQR;STRBP;JMJD6;DDX60
prerank,FAD binding (GO:0071949),0.3201114426415544,0.7447082060732734,0.7438825448613376,1.0,1.0,4/24,14.48%,MICAL2;KMO;MICAL3;CYB5R3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.270981325094917,-0.7446512876896412,0.810958904109589,0.9434581729371165,1.0,6/17,20.94%,LBR;BLVRB;BDH2;DPYD;DECR2;PECR
prerank,kinase inhibitor activity (GO:0019210),-0.23327766519526238,-0.7438372502140522,0.8689655172413793,0.9400584689914367,1.0,16/33,33.85%,MBIP;NCK1;SNCA;SH3BP5L;TRIB1;QARS1;MAPK8IP1;SMCR8;CDKN1A;CDKN1C;SPRY4;SH3BP5;DUSP19;GMFB;SOCS3;WARS1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.24329860730315284,-0.7428530009229486,0.8801169590643275,0.9370476534565677,1.0,11/28,35.53%,AGO3;POP1;EDC3;DBR1;ELAC2;POP4;ENDOV;RPP38;NUDT16;MRPL44;RPP21
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.2659290008898546,-0.7422411631996828,0.8657894736842106,0.9334345841805534,1.0,5/20,16.41%,TJP2;DLG1;MAGI3;CASK;DTYMK
prerank,RNA polymerase binding (GO:0070063),0.3370401036606048,0.7417749384123702,0.7309644670050761,1.0,1.0,5/18,12.06%,NEDD4;STOM;CCNT1;PKN2;YTHDC2
prerank,clathrin adaptor activity (GO:0035615),-0.2808411782742444,-0.7400183283264522,0.8036175710594315,0.9317831943606883,1.0,4/15,13.14%,DAB2;AP1M1;STON2;AP2S1
prerank,chemokine binding (GO:0019956),0.30928277339713084,0.739801460345713,0.7507246376811594,1.0,1.0,4/30,8.26%,ITGB1;CXCR6;ITGB3;ITGA4
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3205090662431972,0.7389044441252824,0.7537993920972644,1.0,1.0,8/24,18.76%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;ZDHHC17;ZDHHC4;ZDHHC8;ZDHHC3
prerank,phosphatase inhibitor activity (GO:0019212),0.3276493862023552,0.7382290023497019,0.7480438184663537,1.0,1.0,7/20,15.29%,SET;SAG;TESC;ENSA;CABIN1;ARPP19;URI1
prerank,RNA cap binding (GO:0000339),-0.2722259237884105,-0.7352517035045494,0.8098591549295775,0.9335059832770499,1.0,5/16,20.60%,CYFIP2;DCPS;LSM1;NCBP2;EIF3D
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.24156395252198104,-0.7315720788189053,0.8641618497109826,0.9338813109395314,1.0,13/24,36.79%,IP6K1;IP6K2;PPIP5K2;DTYMK;ITPKB;NME1;PMVK;AK4;AK1;PPIP5K1;NME2;AK3;AK5
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.24022795799308863,0.7309901837861692,0.988,1.0,1.0,102/732,16.13%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ZFHX3;TBX2;NR1H4;EBF1;ZEB2;RORA;NR4A1;EBF2;GABPA;PRRX1;ETS2;HEYL;TEAD3;IRX5;HINFP;FOSL2;NACC2;PRDM1;NR2F2;NR2C1;SP7;KLF7;TBX18;KCNIP3;MEF2A;KLF16;DBP;FOXJ3;KLF15;JUND;CHD2;TP53;RXRG;GRHL1;ZNF418;ZBTB38;HOXC4;AR;ZFP28;ZNF431;SOX9;SNAI2;HSF4;RELA;ZFP62;ZKSCAN4;PPARA;CARF;NR4A2;SKI;NR1D1;LRRFIP1;ZBTB33;HIF1A;ZBTB41;HNRNPU;NR2C2;TEAD1;SREBF2;RUNX1;ATF3;NKX6-1;ZKSCAN1;ZBTB7A;ESRRA;NR6A1;POU3F3;MED8;ZNF83;MXD4;BCL6;IKZF1;MEF2B;FOXJ1;ZBTB5;RFX7;ZKSCAN7;CLOCK;MTA1;ZBTB4;SP4;RFX1;EBF3;MLXIPL;KLF6;HOXB2;ZSCAN22;STAT1;HOXC5;NR5A1;RFX3;SARS1;ZSCAN18;SP1;STAT3;IKZF4;CALCOCO1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.34544997652961884,0.7276646136091673,0.7703435804701627,1.0,1.0,4/14,17.85%,MTMR7;MTMR14;PTEN;MTMR3
prerank,chemokine receptor activity (GO:0004950),0.3179318562406966,0.7273364637339294,0.7715582450832073,1.0,1.0,2/24,7.60%,CXCR6;GPR17
prerank,manganese ion binding (GO:0030145),0.2798083265600817,0.7259774114805788,0.8051420838971584,1.0,1.0,3/48,2.30%,DYRK2;ADCY2;LARGE1
prerank,potassium:proton antiporter activity (GO:0015386),-0.312446934088649,-0.7253544201480282,0.8089622641509434,0.9369760289756527,1.0,4/10,25.69%,SLC9A2;SLC9A6;SLC9A9;SLC9A5
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.2380668851970294,0.7243068429004051,0.989,1.0,1.0,102/731,16.13%,SOX6;PRDM16;SOX5;MEF2C;HEY2;ZFHX3;TBX2;NR1H4;EBF1;ZEB2;RORA;NR4A1;EBF2;GABPA;PRRX1;ETS2;HEYL;TEAD3;IRX5;HINFP;FOSL2;NACC2;PRDM1;NR2F2;NR2C1;SP7;KLF7;TBX18;KCNIP3;MEF2A;KLF16;DBP;FOXJ3;KLF15;JUND;CHD2;TP53;RXRG;GRHL1;ZNF418;ZBTB38;HOXC4;AR;ZFP28;ZNF431;SOX9;SNAI2;HSF4;RELA;ZFP62;ZKSCAN4;PPARA;CARF;NR4A2;SKI;NR1D1;LRRFIP1;ZBTB33;HIF1A;ZBTB41;HNRNPU;NR2C2;TEAD1;SREBF2;RUNX1;ATF3;NKX6-1;ZKSCAN1;ZBTB7A;ESRRA;NR6A1;POU3F3;MED8;ZNF83;MXD4;BCL6;IKZF1;MEF2B;FOXJ1;ZBTB5;RFX7;ZKSCAN7;CLOCK;MTA1;ZBTB4;SP4;RFX1;EBF3;MLXIPL;KLF6;HOXB2;ZSCAN22;STAT1;HOXC5;NR5A1;RFX3;SARS1;ZSCAN18;SP1;STAT3;IKZF4;CALCOCO1
prerank,mRNA binding (GO:0003729),0.23875318658245276,0.7235661084787463,0.9166666666666666,1.0,1.0,40/249,14.16%,RBPMS;RBPMS2;RBM24;KHDRBS3;HNRNPR;CRYZ;SAMD4A;DENR;MRPL13;RBMS3;PARN;PCF11;TP53;CPEB1;CIRBP;YTHDF2;CELF1;SRSF4;SRRM3;EIF4A1;PPIE;ZC3H11A;SECISBP2L;RPL5;PTBP2;RBM8A;HNRNPU;DCP1A;HNRNPC;XPO5;CPEB3;SF3B1;DCP1B;PCBP3;ZFP36L1;RBM25;DXO;SYNCRIP;NUP98;G3BP1
prerank,transcription corepressor binding (GO:0001222),0.30403915838459983,0.7224523195057473,0.7979502196193266,1.0,1.0,3/27,11.69%,RORA;NR1D1;ZBTB7A
prerank,peptidase activator activity (GO:0016504),0.31554112118950023,0.7216497798166026,0.8028846153846154,1.0,1.0,4/22,11.10%,ADRM1;CAV1;PSME4;CASP8AP2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.34908556069273405,0.72021525265139,0.7567084078711985,1.0,1.0,1/11,4.10%,KCNE4
prerank,histone deacetylase activity (GO:0004407),0.3274371417980626,0.7200510487963747,0.7949526813880127,1.0,1.0,6/19,18.90%,HDAC9;SIRT3;SIRT2;SIRT6;HDAC1;HDAC6
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.30731441239937723,-0.7181999348142771,0.7891440501043842,0.9410722858811086,1.0,4/10,30.83%,ATXN3;CYLD;TNFAIP3;YOD1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.35044193700962073,0.714941771390955,0.7711538461538462,1.0,1.0,3/10,9.03%,ASH1L;SETD3;NSD3
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.34537236689031214,0.7147392764059505,0.7862318840579711,1.0,1.0,2/11,15.30%,CHRNA7;CHRNA4
prerank,DNA polymerase activity (GO:0034061),0.3106168462055857,0.7126757122440122,0.794392523364486,1.0,1.0,4/22,11.83%,CHRAC1;TERT;POLD1;POLG
prerank,transcription coregulator binding (GO:0001221),0.27088975155844364,0.7121896349270782,0.8307692307692308,1.0,1.0,7/50,11.69%,RORA;CHD6;TERT;AR;RELA;NR1D1;ZBTB7A
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3489123312134854,0.7112650319707032,0.7758007117437722,1.0,1.0,2/11,8.20%,NAA25;NAA20
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.23216540787219483,0.7088781060731659,0.977977977977978,1.0,1.0,57/597,11.80%,SOX6;PRDM16;SOX5;MEF2C;HEY2;TBX2;ALX4;NR4A1;GABPA;ETS2;ARID5B;IRX5;HINFP;PRDM1;NR2C1;MTERF3;OSR2;TBX18;KLF16;DBP;FOXJ3;KLF15;SUV39H2;JUND;MLH3;ARID5A;TP53;RXRG;GRHL1;SFPQ;HOXC4;AR;MBD4;YAP1;SOX9;SNAI2;HSF4;RELA;KMT2D;CUX2;MBNL2;BBX;NR4A2;NR1D1;KAT7;ZBTB33;HNRNPU;MCMDC2;NR2C2;TEAD1;SREBF2;RUNX1;ATF3;HOXC8;ZBTB7A;ESRRA;PSPC1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.25902524090538825,-0.7077964222493053,0.8511749347258486,0.948571305121542,1.0,4/18,14.61%,RPS6KA3;BIRC2;SNCA;BIRC3
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.2843302185059682,0.7069342440058742,0.8360655737704918,1.0,1.0,4/35,9.30%,FRK;PEAK1;DYRK1A;SLA
prerank,O-acyltransferase activity (GO:0008374),0.29535304434415377,0.7059904250751433,0.8163884673748103,1.0,1.0,9/30,20.64%,LPCAT3;DGAT1;PLA2G4A;PLA2G4C;PRDX6;MBOAT7;GPAT3;LPCAT1;PLA2G15
prerank,phosphatidate phosphatase activity (GO:0008195),-0.27858787204613766,-0.7018796531636271,0.8404761904761905,0.9509741314655672,1.0,8/13,45.63%,LPIN2;PLPP5;LPIN3;LPIN1;PLPPR3;PLPP2;PLPP1;PLPPR4
prerank,cAMP binding (GO:0030552),0.33928336106488693,0.6986449640543532,0.7945945945945946,1.0,1.0,2/11,11.18%,PDE4A;PDE4D
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.21764666462285404,-0.6974751487924189,0.9100346020761245,0.9510949452282942,1.0,16/34,30.62%,DDX3X;IGF2;MAP2K2;CAB39L;IRGM;SPRY2;TAOK1;CCNT2;CCNK;ALS2;CDK5R1;DBF4;CALM3;INCENP;PARP16;CALM2
prerank,endopeptidase activator activity (GO:0061133),0.34679827870240665,0.6955867067341566,0.7544802867383512,1.0,1.0,1/10,2.96%,ADRM1
prerank,GABA receptor binding (GO:0050811),0.33612004807724005,0.6904397998384275,0.8217993079584776,1.0,1.0,2/11,8.64%,GABARAP;TRAK1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.28444988675888805,-0.6901188377005087,0.8578199052132701,0.9548729422866944,1.0,5/13,19.45%,SLC66A1;SLC38A5;SLC38A7;SLC7A7;SLC15A4
prerank,enoyl-CoA hydratase activity (GO:0004300),0.3395767614110935,0.689830941288186,0.7861060329067642,1.0,1.0,4/10,15.79%,HSD17B4;HADHB;ECI1;HADHA
prerank,ribonuclease P activity (GO:0004526),-0.28976403274256773,-0.6867378427418446,0.8823529411764706,0.9539869552185686,1.0,4/11,35.53%,POP1;POP4;RPP38;RPP21
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.22069176370334334,-0.6865120745114691,0.9196141479099679,0.949919226864266,1.0,5/30,14.61%,BIRC6;RPS6KA3;BIRC2;SNCA;BIRC3
prerank,methylation-dependent protein binding (GO:0140034),-0.18711963653549543,-0.6844518170680106,0.9903381642512077,0.947585267726017,1.0,12/57,19.92%,KDM7A;KMT2E;CBX5;ZMYND8;TRIM24;MORC4;CHD1;NCAPG2;MPHOSPH8;FMR1;RRP8;MSH6
prerank,tRNA methyltransferase activity (GO:0008175),0.31260699529785274,0.6832945062411712,0.8200339558573854,1.0,1.0,2/16,5.49%,TRDMT1;FTSJ1
prerank,phosphatase activity (GO:0016791),0.24441250954828922,0.6824620198880508,0.8913043478260869,1.0,1.0,12/73,13.93%,DUSP5;ACP3;PRUNE1;LHPP;DUSP3;SACM1L;PLPPR1;PPP1CB;PPP1CA;SBF1;DUSP16;NT5M
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.27681465004273215,0.6823935259602424,0.8571428571428571,1.0,1.0,10/31,19.35%,TAF1;UBE2W;UBE2E1;UBE2D1;AKTIP;UBE2J1;UBE2K;UBE2L6;UBE2A;UBE2Q1
prerank,3'-5' exonuclease activity (GO:0008408),0.2669516099647681,0.6814944888674708,0.8720316622691293,1.0,1.0,9/45,11.83%,PARN;ERI2;REXO4;RAD9A;DIS3L2;DIS3L;POLD1;CNOT7;POLG
prerank,RNA methyltransferase activity (GO:0008173),0.30779103593845114,0.6796101192292839,0.8245315161839863,1.0,1.0,3/19,12.14%,TRDMT1;FTSJ1;TGS1
prerank,endopeptidase regulator activity (GO:0061135),0.2694187638533805,0.6789002610250058,0.8459495351925631,1.0,1.0,2/40,2.96%,ITIH4;ADRM1
prerank,protein phosphatase activator activity (GO:0072542),0.3224807091693012,0.6785688345076218,0.8162162162162162,1.0,1.0,2/13,7.02%,PPP2R5A;CALM1
prerank,mRNA 3'-UTR binding (GO:0003730),0.24689651055945103,0.6773162177245761,0.9050480769230769,1.0,1.0,14/79,13.20%,RBM24;CRYZ;RBMS3;PARN;TP53;CPEB1;CIRBP;CELF1;SECISBP2L;RPL5;HNRNPU;HNRNPC;CPEB3;ZFP36L1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2660437751527934,0.6742272862094586,0.8662873399715505,1.0,1.0,4/35,8.00%,TRDMT1;FTSJ1;GATB;FTO
prerank,disordered domain specific binding (GO:0097718),0.28651276383732455,0.6705214566467019,0.8517985611510791,1.0,1.0,5/23,11.19%,TP53;CALM1;BCL2L2;PPIL1;RB1
prerank,N-methyltransferase activity (GO:0008170),0.29646491003434705,0.6689185504428471,0.8473520249221184,1.0,1.0,5/20,14.56%,SETD3;TFB2M;ZCCHC4;N6AMT1;NNMT
prerank,cytochrome-c oxidase activity (GO:0004129),0.2997287187320551,0.6683328948988595,0.8552412645590682,1.0,1.0,2/15,7.26%,COX7A2L;COX8A
prerank,phospholipase inhibitor activity (GO:0004859),0.3334504180549581,0.6676609730562331,0.8117229129662522,1.0,1.0,2/10,10.89%,ANXA1;ANXA9
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3265290460624473,0.6644166676925434,0.8432432432432433,1.0,1.0,3/10,8.72%,PKIB;PKIA;PRKAR1B
prerank,ribosome binding (GO:0043022),0.2536782045015591,0.6634279983344037,0.8696219035202086,1.0,1.0,15/46,21.24%,SRP68;CPEB1;PYM1;SRP72;CPEB3;SRP19;SEC61B;ETF1;EEF2;SERBP1;ERI1;C1QBP;EIF2S1;EIF2A;OXA1L
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.2565910892000726,-0.6631807489978062,0.8946188340807175,0.9620392715205943,1.0,4/14,16.66%,NOD1;CTSH;MAL;APAF1
prerank,translation initiation factor activity (GO:0003743),0.2689358236183504,0.6625519215861112,0.8667601683029453,1.0,1.0,11/36,20.44%,EIF1;EIF3M;EIF2D;EIF4A1;EIF3E;EIF3H;EIF4E;EIF4E3;EIF4G2;EIF2S1;EIF2A
prerank,sequence-specific DNA binding (GO:0043565),0.21650027392221274,0.660742943664741,0.9949849548645938,1.0,1.0,59/590,11.77%,PRDM16;MEF2C;HEY2;TBX2;NR1H4;ZEB2;ALX4;RORA;NR4A1;GABPA;ETS2;IRX5;PRDM1;SIRT3;NR2F2;NR2C1;BCL2;UPF1;OSR2;ZCWPW1;CBFB;TBX18;MEF2A;KLF16;DBP;FOXJ3;KLF15;MYBBP1A;JUND;TAF1;MAPT;ARID5A;TERT;RXRG;GRHL1;ZBTB38;HOXC4;PPARGC1A;SOX9;SNAI2;HSF4;CUX2;PPARA;MBNL2;BBX;LONP1;NR4A2;NR1D1;ZBTB33;HIF1A;HNRNPU;NR2C2;TEAD1;SREBF2;ATF3;HOXC8;TERF2;ZBTB7A;ESRRA
prerank,phosphatase activator activity (GO:0019211),0.308939388178992,0.6555940565031091,0.85,1.0,1.0,2/14,7.02%,PPP2R5A;CALM1
prerank,ubiquitin protein ligase binding (GO:0031625),0.215486819528181,0.6530910998035402,0.9732785200411099,1.0,1.0,47/254,15.53%,VCL;FZD5;FZD4;ACTG1;MFHAS1;BCL2;USP2;PIAS4;CUL2;FZD8;GABARAP;TP53;FBXW7;UBE2W;PA2G4;PPARGC1A;TRAF3;DIO2;RELA;AUP1;PRKACB;WASHC1;SKI;RPL5;HIF1A;TRAF5;UBE2D1;DNM1L;ANKRA2;RB1;MFN2;CCDC50;ACVR1B;NDUFS2;USP13;TSG101;CLU;SNX9;UBE2J1;MUL1;TRIM28;CKB;HM13;PRKACA;UBE2K;UBE2L6;HSPBP1
prerank,lipid phosphatase activity (GO:0042577),0.3075202671940006,0.6518739153482095,0.8253706754530478,1.0,1.0,2/14,9.88%,PLPPR1;PLPP7
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.24081283272706527,0.651008325189219,0.9178921568627451,1.0,1.0,22/69,21.75%,ZDHHC2;LPCAT3;CERS1;HHAT;ZDHHC1;SCP2;ZDHHC14;ZDHHC17;DGAT1;PLA2G4A;PLA2G4C;ELP3;ZDHHC13;ZDHHC5;ZDHHC8;ESCO1;ZDHHC3;KAT8;MBOAT7;PLA2G15;KAT6A;NMT1
prerank,O-methyltransferase activity (GO:0008171),-0.27561884027648087,-0.6485881047300238,0.8973799126637555,0.9693448438260346,1.0,5/10,38.22%,FTSJ3;CMTR1;COQ3;BCDIN3D;CMTR2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3052419889706026,0.6474128405353129,0.8315018315018315,1.0,1.0,3/12,11.10%,RPS27L;ATP2A3;CASP8AP2
prerank,channel activity (GO:0015267),0.24853480215820917,0.6436944726207399,0.9087136929460581,1.0,1.0,5/41,12.38%,BCL2;TRPV2;PANX1;KCNK3;CHRNA7
prerank,MHC class II protein complex binding (GO:0023026),0.3102835099811331,0.6389107528705706,0.8402777777777778,1.0,1.0,3/11,19.37%,ATP1B1;ANXA11;PKM
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.24034961027012702,-0.6320982488505278,0.9317073170731708,0.9769906513530432,1.0,1/15,4.69%,CCR9
prerank,flavin adenine dinucleotide binding (GO:0050660),0.23796258861153818,0.6311006130144764,0.9027397260273973,1.0,1.0,11/53,15.59%,MICAL2;LDHD;DLD;KMO;ETFA;FOXRED2;GFER;SDHA;MICAL3;CYB5R3;NOS1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3006043545856356,0.6297949967188081,0.8882978723404256,1.0,1.0,4/13,19.09%,ARHGDIG;SH3BP4;GDI2;RANBP1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.31100385762741845,0.6261221027389868,0.8645640074211502,1.0,1.0,3/10,16.55%,POLD1;EXD2;MGME1
prerank,NF-kappaB binding (GO:0051059),0.26022168839920823,0.6221421095536496,0.8944954128440367,1.0,1.0,3/24,7.89%,SETD6;MTDH;RELA
prerank,signaling receptor complex adaptor activity (GO:0030159),0.25376525456546106,0.6212153140930274,0.9095816464237517,1.0,1.0,10/38,15.88%,NUP62;IRS1;SORBS1;SAV1;DEDD2;SHANK2;LDLRAP1;NCK2;LRRK2;SPAG9
prerank,ionotropic glutamate receptor activity (GO:0004970),0.27864979157429676,0.6209849619162707,0.8764227642276423,1.0,1.0,2/17,8.76%,GRIN2C;GRIK5
prerank,kinesin binding (GO:0019894),0.26394837773467217,0.6201356109371002,0.8844444444444445,1.0,1.0,6/27,16.81%,FAM83D;ACTB;ATCAY;KIFAP3;SPAG9;CLSTN1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.2867547137007762,0.6141759869928403,0.8913793103448275,1.0,1.0,3/16,13.12%,ATP6V0A2;ATP6V1C1;ATP6V0D2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.2867547137007762,0.6141759869928403,0.8913793103448275,1.0,1.0,3/16,13.12%,ATP6V0A2;ATP6V1C1;ATP6V0D2
prerank,dipeptidyl-peptidase activity (GO:0008239),0.30441193065888794,0.6126774780182814,0.8696461824953445,1.0,1.0,2/10,12.98%,DPP10;DPP8
prerank,histone methyltransferase activity (GO:0042054),0.24924042873870156,0.610400361802995,0.8982808022922636,1.0,1.0,3/32,9.03%,SMYD1;PRMT7;NSD3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.2484420140244658,0.6073408022289186,0.9137199434229137,1.0,1.0,10/33,22.32%,PCF11;AR;HNRNPU;URI1;ELOF1;DHX9;AGO1;WDR43;RPRD1A;CCAR2
prerank,CoA hydrolase activity (GO:0016289),0.2770230421065989,0.6066977645919188,0.8859649122807017,1.0,1.0,1/16,3.02%,NUDT7
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.2265018775151438,-0.6026932049671628,0.9435897435897436,0.9914859701911325,1.0,10/16,46.41%,CD38;SMUG1;ADPRS;TDG;NEIL1;NEIL3;NTHL1;ADPRH;NEIL2;BST1
prerank,histone acetyltransferase activity (GO:0004402),0.24712007361279564,0.6024568503139932,0.9055007052186178,1.0,1.0,10/30,20.94%,TAF1;EPC2;KAT7;MCM3AP;HAT1;CLOCK;TADA3;KAT8;KAT14;KAT6A
prerank,steroid hydroxylase activity (GO:0008395),0.28231038206012626,0.5980537958296791,0.8821603927986906,1.0,1.0,1/16,3.15%,CYP7B1
prerank,myosin V binding (GO:0031489),0.27488812548902736,0.5975288623941943,0.8973941368078175,1.0,1.0,3/15,16.59%,RAB3A;RAB14;RAB8A
prerank,methyl-CpG binding (GO:0008327),0.25450600791558364,0.5903538191961835,0.919047619047619,1.0,1.0,4/22,14.21%,ZCWPW1;ZBTB38;ZBTB33;ZBTB4
prerank,MHC protein binding (GO:0042287),0.2686838709465433,0.5884980828682861,0.9063492063492063,1.0,1.0,1/20,4.01%,LAG3
prerank,NAD binding (GO:0051287),0.24642363389342117,0.5864942929001139,0.9321789321789322,1.0,1.0,6/26,16.51%,CRYZ;SIRT3;SIRT2;QDPR;HADH;SIRT6
prerank,CCR chemokine receptor binding (GO:0048020),0.2411374103542601,0.5853357533057598,0.9193776520509194,1.0,1.0,4/28,18.77%,CCL5;CCL14;CCL25;CCL19
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.2790752586750852,0.5832917772089334,0.9051724137931034,1.0,1.0,2/12,11.80%,PARN;CNOT7
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.17038483929664228,-0.583024334736749,0.9781021897810219,0.9968879557394027,1.0,10/40,23.16%,PCMTD1;HNMT;TARBP1;AS3MT;THUMPD3;ARMT1;RRP8;TPMT;SUV39H1;THUMPD2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.2537269160876456,0.5791358045753612,0.9255150554675119,1.0,1.0,7/22,19.27%,ANKRA2;CLU;LDLRAP1;SNX17;HSPG2;LANCL1;CLTC
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.23618741567828716,0.5768173321739303,0.9366197183098591,1.0,1.0,11/35,21.18%,TAF1;SMARCB1;TP53;RELA;BAZ2A;STAT1;HDAC1;AGO1;RRN3;POU2F1;H3-3A
prerank,glutathione transferase activity (GO:0004364),0.2478030433032888,0.573077675232877,0.92,1.0,1.0,3/23,12.11%,GSTT1;GSTP1;GSTA4
prerank,mitogen-activated protein kinase binding (GO:0051019),0.23752927973252702,0.5697335423434998,0.9409221902017291,1.0,1.0,3/29,8.19%,DUSP5;MAPKAPK2;TNIP1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.23258811961965978,0.5696800365001231,0.9414285714285714,1.0,1.0,11/33,22.32%,PCF11;HNRNPU;URI1;ELOF1;DHX9;AGO1;RRN3;WDR43;ERBB2;RPRD1A;CCAR2
prerank,adenyl nucleotide binding (GO:0030554),-0.24259831938683593,-0.569258216814847,0.928921568627451,0.9943136238473937,1.0,3/11,13.52%,BAG4;BAG1;PFN1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.24259831938683593,-0.569258216814847,0.928921568627451,0.9943136238473937,1.0,3/11,13.52%,BAG4;BAG1;PFN1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.21654053669545306,-0.5675191823768184,0.9716981132075472,0.9907024502948051,1.0,3/14,17.61%,ALDH4A1;BLVRB;ALDH1L1
prerank,chemokine receptor binding (GO:0042379),-0.17196474351507235,-0.5674449004825313,0.989247311827957,0.9864859649906456,1.0,4/35,15.56%,ITCH;CXCL16;CX3CL1;CKLF
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.24551584288025802,-0.5673583970262768,0.959051724137931,0.9822744334165259,1.0,2/10,12.16%,CXADR;SIRPA
prerank,MAP kinase kinase activity (GO:0004708),0.26464387749658325,0.563581520472804,0.9266547406082289,1.0,1.0,4/15,15.49%,MAP2K1;MAP2K3;LRRK2;MAP2K4
prerank,mRNA methyltransferase activity (GO:0008174),-0.2261814279722127,-0.563053350443551,0.962877030162413,0.979654186622754,1.0,5/12,28.18%,METTL3;METTL14;METTL16;CMTR1;METTL8
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.26144229814103714,0.5622292451434294,0.9296740994854202,1.0,1.0,2/15,8.08%,KMT2D;SETD3
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.22615816275361383,0.5529602881477484,0.9579945799457995,1.0,1.0,9/34,20.12%,PARN;ERI2;DIS3L2;DIS3L;CNOT7;EXD2;REXO2;EXOSC10;ERI1
prerank,triglyceride lipase activity (GO:0004806),0.24749798051500213,0.5492037102292178,0.9450915141430949,1.0,1.0,1/20,3.34%,LPL
prerank,exopeptidase activity (GO:0008238),0.21227774135794172,0.5475992314488692,0.9708222811671088,1.0,1.0,12/50,21.37%,LNPEP;RNPEP;BLMH;ENPEP;DPP10;DPP8;CTSA;METAP1;TRHDE;CNDP2;KDM8;XPNPEP3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.22712892188857756,0.5474441407095548,0.9657534246575342,1.0,1.0,9/33,20.12%,PARN;ERI2;DIS3L2;DIS3L;CNOT7;EXD2;REXO2;EXOSC10;ERI1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.21357703146456652,-0.5436842968648747,0.9626168224299065,0.9821004809690703,1.0,2/14,16.75%,CAPNS1;CAPN10
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.2330954485264219,0.5334596401528396,0.9614197530864198,1.0,1.0,3/21,11.83%,CHRAC1;POLD1;POLG
prerank,snoRNA binding (GO:0030515),0.2187116181448293,0.5317515812400703,0.9777448071216617,1.0,1.0,2/30,4.45%,NUDT7;NUDT4
prerank,phosphate ion binding (GO:0042301),0.26525386328050904,0.5292645237352755,0.9420289855072463,1.0,1.0,3/10,18.15%,RELA;ADSS1;RPH3A
prerank,C-C chemokine receptor activity (GO:0016493),0.23289829026329895,0.5200962335715399,0.9640625,1.0,1.0,1/21,5.56%,CXCR6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.26285470882023787,0.5172253130874903,0.9341864716636198,1.0,1.0,1/10,6.71%,HEXIM1
prerank,nucleotide diphosphatase activity (GO:0004551),0.24082133146761325,0.5125363176551555,0.9565217391304348,1.0,1.0,2/14,10.22%,NUDT4;NUDT13
prerank,deoxyribonuclease activity (GO:0004536),0.23580772130455507,0.5119178496686346,0.9523809523809523,1.0,1.0,4/14,18.33%,MBD4;DNASE1L1;ZRANB3;MAP1S
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.24133013745143234,0.5105306942064448,0.9359861591695502,1.0,1.0,3/14,18.40%,AK7;CMPK1;CMPK2
prerank,chemokine activity (GO:0008009),0.20628507468527915,0.5088924436266264,0.9758179231863442,1.0,1.0,2/31,10.43%,CCL5;CCL14
prerank,aspartic-type endopeptidase activity (GO:0004190),0.24356634140711073,0.4985976830967732,0.9599303135888502,1.0,1.0,3/12,14.38%,DDI2;HM13;SPPL2B
prerank,adrenergic receptor binding (GO:0031690),0.22683713548723472,0.491704941595413,0.9816666666666667,1.0,1.0,3/16,11.18%,NEDD4;SAV1;PDE4D
prerank,proton transmembrane transporter activity (GO:0015078),0.19289660280592946,0.4915647092139443,0.9837618403247632,1.0,1.0,11/39,22.44%,COX7A2L;COX8A;UQCRFS1;UQCRH;COX5B;UQCRQ;SLC11A2;CLCN5;COX6A1;SLC9A1;ATP6V1F
prerank,methylated histone binding (GO:0035064),0.18360504766782468,0.48362203781926244,0.9975186104218362,1.0,1.0,7/62,9.37%,ZCWPW1;NCAPD3;TAF1;L3MBTL2;MSL3;TDRD3;CDYL
prerank,ligand-gated channel activity (GO:0022834),0.1965863590227677,0.47818941771129303,0.9815668202764977,1.0,1.0,4/29,16.82%,GRIN2C;GRIK5;CHRNA4;GRIK4
prerank,ligand-gated ion channel activity (GO:0015276),0.19451998150518207,0.47455349766287197,0.9846860643185299,1.0,1.0,4/30,16.82%,GRIN2C;GRIK5;CHRNA4;GRIK4
prerank,aspartic-type peptidase activity (GO:0070001),-0.2021137197432679,-0.47335935313164096,0.9844789356984479,0.993232347265181,1.0,5/10,45.90%,BACE2;CTSD;PSEN1;CTSE;BACE1
prerank,C-C chemokine binding (GO:0019957),0.20781664023336288,0.46789606274661183,0.9765990639625585,1.0,1.0,1/22,5.56%,CXCR6
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.19272724186341597,0.4646315149402678,0.986822840409956,0.9988145986546625,1.0,4/29,11.20%,NEU3;GLA;GANC;PARG
prerank,purinergic nucleotide receptor activity (GO:0001614),0.20711953792064272,0.4432882927941705,0.9830508474576272,1.0,1.0,15/15,79.31%,P2RX4;P2RY14;GPR34;P2RX6;P2RX7;P2RX2;P2RY13;GPR87;P2RX1;GPR171;P2RX3;P2RX5;PTAFR;P2RY12;P2RY1
prerank,DNA replication origin binding (GO:0003688),0.18957628133621346,0.4360688139876119,0.985981308411215,1.0,1.0,4/23,16.80%,KAT7;MCMDC2;ORC2;DHX9
prerank,neuropeptide receptor binding (GO:0071855),0.19781530541779166,0.418467539492492,0.988013698630137,1.0,1.0,14/14,80.24%,NTS;NPY;UCN3;APELA;QRFP;GHRH;NPPA;UCN2;GAL;AGRP;APLN;SHANK1;NMU;PPY
prerank,1-phosphatidylinositol binding (GO:0005545),0.19269684275470278,0.41632685706766726,0.986863711001642,0.9985816558925908,1.0,4/15,21.46%,SNX9;SNAP91;ZFYVE16;ZFYVE9
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.17480623361097125,0.4080314905456994,1.0,0.9973259443491194,1.0,3/21,18.02%,CHRNA7;CHRNA4;P2RX4
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.1837923345976772,0.4001228746035315,0.9932432432432432,0.9960261875105056,1.0,1/17,4.87%,AK7
